Have a personal or library account? Click to login
Evidence From the Scientific Assessment of Electronic Cigarettes and Their Role in Tobacco Harm Reduction Cover

Evidence From the Scientific Assessment of Electronic Cigarettes and Their Role in Tobacco Harm Reduction

Open Access
|May 2021

References

  1. U.S. Department of Health and Human Services (HHS): Smoking Cessation: A Report of the Surgeon General; 2020. Available at: https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf (accessed July 6, 2020)
  2. World Health Organization (WHO): Tobacco: Health Benefits of Smoking Cessation; 2020. Available at: https://www.who.int/tobacco/quitting/benefits/en/ (accessed April 29, 2020)
  3. Baker, R.R. and L.J. Bishop: The Pyrolysis of Tobacco Ingredients; J. Anal. Appl. Pyrolysis 71 (2004) 223–311. DOI: 10.1016/j.jaap.2004.10.01
  4. Gottlieb, S. and M. Zeller: A Nicotine-Focused Framework for Public Health; N. Engl. J. Med. 377 (2017) 1111–1114. DOI: 10.1056/NEJMp1707409
  5. Rodgman, A. and T.A. Perfetti: The Chemical Components of Tobacco and Tobacco Smoke; CRC Press, Boca Raton, FL, USA, 2013.
  6. Fowles, J. and E. Dybing: Application of Toxicological Risk Assessment Principles to the Chemical Constituents of Cigarette Smoke; Tob. Control 12 (2003) 424–430. DOI: 10.1136/tc.12.4.424
  7. Fagerström, K.: The Epidemiology of Smoking: Health Consequences and Benefits of Cessation; Drugs 62, Suppl. 2 (2002) 1–9. DOI: 10.2165/00003495-200262002-00001
  8. World Health Organization (WHO): Partial Guidelines for Implementation of Articles 9 and 10 of the WHO Framework Convention on Tobacco Control. Regulation of the Contents of Tobacco Products and of Tobacco Product Disclosures; 2010. Available at: https://www.who.int/fctc/guidelines/Guideliness_Articles_9_10_rev_240613.pdf#:~:text=The%20purpose%20of%20the%20guidelines%20is%20to%20assist,evidence%20and%20the%20experience%20of%20Parties%2C%20propose%20measures (accessed September 7, 2020)
  9. World Health Organization Framework Convention on Tobacco Control (FCTC): Conference of the Parties to the WHO Framework Convention on Tobacco Control. Sixth Session; Moscow, Russian Federation, 13–18 October, 2014. Available at: https://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6(9)-en.pdf?ua=1 (accessed April 29, 2020)
  10. Bates, C.: Tobacco Harm Reduction – A Note to WHO's Expert Committee; 2013. Available at: https://www.clivebates.com/tobacco-harm-reduction-a-note-to-whos-expert-commitee (accessed September 7, 2020)
  11. Stratton, K., P. Shetty, R. Wallace, and S. Bondurant: Clearing the Smoke: The Science Base for Tobacco Harm Reduction—Executive Summary; Tob. Control 10 (2001) 189–195. DOI: 10.1136/tc.10.2.189
  12. Rodu, B. and W.T. Godshall: Tobacco Harm Reduction: An Alternative Cessation Strategy for Inveterate Smokers; Harm Reduct. J. 3 (2006) 37. DOI: 10.1186/1477-7517-3-37
  13. Institute of Medicine: Scientific Standards for Studies on Modified Risk Tobacco Products; The National Academies Press, Washington, DC, USA, 2012. DOI: 10.17226/13294
  14. European Commission: Special Eurobarometer 506. Attitudes of Europeans Towards Tobacco and Electronic Cigarettes; 2021. Available at https://ec.europa.eu/commfrontoffice/publicopinion/index.cfm/survey/getsurveydetail/instruments/special/surveyky/2240 (accessed April 11, 2021)
  15. Clarke, E., K. Thompson, S. Weaver, J. Thompson, and G. O’Connell: Snus: A Compelling Harm Reduction Alternative to Cigarettes; Harm Reduct. J. 16 (2019) 62. DOI: 10.1186/s12954-019-0335-1
  16. Ferlay, J., M. Ervik, F. Lam, M. Colombet, L. Mery, M. Piñeros, A. Znaor, I. Soerjomataram, and F. Bray: Cancer Today (Powered by GLOBCAN 2018). Available at: https://publications.iarc.fr/Databases/Iarc-Cancerbases/Cancer-Today-Powered-By-GLOBOCAN-2018--2018 (accessed September 7, 2020)
  17. U.S. Food and Drug Administration (FDA): FDA Grants First-Ever Modified Risk Orders to Eight Smokeless Tobacco Products; FDA News relase, October 22, 2019. Available at: https://www.fda.gov/news-events/press-announcements/fda-grants-first-ever-modified-risk-orders-eight-smokeless-tobacco-products (accessed January 25, 2021)
  18. U.S. Food and Drug Administration (FDA): FDA Authorizes Modified Risk Tobacco Products; 2019. Available at: https://www.fda.gov/tobacco-products/advertising-and-promotion/fda-authorizes-modified-risk-tobacco-products (accessed January 25, 2021)
  19. Marco, E. and J.O. Grimalt: A Rapid Method for the Chromatographic Analysis of Volatile Organic Compounds in Exhaled Breath of Tobacco Cigarette and Electronic Cigarette Smokers; J. Chromatogr. A 1410 (2015) 51–59. DOI: 10.1016/j.chroma.2015.07.094
  20. Margham, J., K. McAdam, M. Forster, C. Liu, C. Wright, D. Mariner, and C. Proctor: Chemical Composition of Aerosol from an E-Cigarette: A Quantitative Comparison with Cigarette Smoke; Chem. Res. Toxicol. 29 (2016) 1662–1678. DOI: 10.1021/acs.chemrestox.6b00188
  21. Nicol, J., R. Fraser, L. Walker, C. Liu, J. Murphy, and C.J. Proctor: Comprehensive Chemical Characterization of the Aerosol Emissions of a Vaping Product Based on a New Technology; Chem. Res. Toxicol. 33 (2020) 789–799. DOI: 10.1021/acs.chemrestox.9b00442
  22. Cunningham, A., K. McAdam, J. Thissen, and H. Digard: The Evolving E-cigarette: Comparative Chemical Analyses of E-Cigarette Vapor and Cigarette Smoke; Front. Toxicol. 2 (2020) 586674. DOI: 10.3389/ftox.2020.586674
  23. Hartmann-Boyce, J., H. McRobbie, N. Lindson, C. Bullen, R. Begh, A. Theodoulou, C. Notley, N.A. Rigotti, T. Turner, A.R. Butler, T.R. Fanshawe, and P. Hajek: Electronic Cigarettes for Smoking Cessation; Cochrane Database Syst. Rev. 10 (2020) CD010216. DOI: 10.1002/14651858.CD010216.pub4
  24. McNeill, A., L.S. Brose, R. Calder, S.C. Hitchman, P. Hajek, and H. McRobbie: E-Cigarettes: An Evidence Update. A Report Commissioned by Public Health England; 2015. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/733022/Ecigarettes_an_evidence_update_A_report_commissioned_by_Public_Health_England_FINAL.pdf (accessed April 15, 2021)
  25. McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Vaping in England: An Evidence Update. A Report Commissioned by Public Health England; 2019. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/821179/Vaping_in_England_an_evidence_update_February_2019.pdf (accessed April 15, 2021)
  26. McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Vaping in England: An Evidence Update Including Mental Health and Pregnancy. A Report Commissioned by Public Health England; 2020. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/869401/Vaping_in_England_evidence_update_March_2020.pdf (accessed April 15, 2021)
  27. McRobbie, H., C. Bullen, J. Hartmann-Boyce, and P. Hajek: Electronic Cigarettes for Smoking Cessation and Reduction; Cochrane Database Syst. Rev. 12 (2014) CD010216. DOI: 10.1002/14651858.CD010216.pub2
  28. National Academies of Sciences Engineering and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems: Public Health Consequences of E-Cigarettes; edited by D.L. Eaton, L.Y. Kwan and K. Stratton, National Academies Press, Washington, DC, USA, 2018. DOI: 10.17226/24952
  29. McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Evidence Review of E-Cigarettes and Heated Tobacco Products 2018. A Report Commissioned by Public Health England; 2018. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/684963/Evidence_review_of_e-cigarettes_and_heated_tobacco_products_2018.pdf (accessed April 15, 2021)
  30. Government of Canada: Tobacco and Vaping Products Act (TVPA); 2018. Available at: https://www.canada.ca/en/health-canada/services/health-concerns/tobacco/legislation/federal-laws/tobacco-act.html (accessed January 25, 2021)
  31. New Zealand Ministry of Health: Vaping Facts; 2019. Available at: https://vapingfacts.health.nz (accessed August 13, 2020)
  32. Girvalaki, C., A. Vardavas, M. Tzatzarakis, C.N. Kyriakos, K. Nikitara, A.M. Tsatsakis, and C.I. Vardavas: Compliance of E-Cigarette Refill Liquids with Regulations on Labelling, Packaging and Technical Design Characteristics in Nine European Member States; Tob. Control 29 (2020) 531–536. DOI: 10.1136/tobaccocontrol-2019-055061
  33. Seitz, C.M. and Z. Kabir: Burn Injuries Caused by E-Cigarette Explosions: A Systematic Review of Published Cases; Tob. Prev. Cessat. 4 (2018) 32. DOI: 10.18332/tpc/94664
  34. Blount, B.C., M.P. Karwowski, P.G. Shields, M. Morel-Espinosa, L. Valentin-Blasini, M. Gardner, M. Braselton, C.R. Brosius, K.T. Caron, D. Chambers, J. Corstvet, E. Cowan, V.R. De Jesús, P. Espinosa, C. Fernandez, C. Holder, Z. Kuklenyik, J.D. Kusovschi, C. Newman, G.B. Reis, J. Rees, C. Reese, L. Silva, T. Seyler, M.A. Song, C. Sosnoff, C.R. Spitzer, D. Tevis, L. Wang, C. Watson, M.D. Wewers, B. Xia, D.T. Heitkemper, I. Ghinai, J. Layden, P. Briss, B.A. King, L.J. Delaney, C.M. Jones, G.T. Baldwin, A. Patel, D. Meaney-Delman, D. Rose, V. Krishnasamy, J.R. Barr, J. Thomas, and J.L. Pirkle: Lung Injury Response Laboratory Working Group: Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI; N. Engl. J. Med. 382 (2020) 697–705. DOI: 10.1056/NEJMoa1916433
  35. Centers for Disease Control and Prevention (CDC): Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products; 2020. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html (accessed September 7, 2020)
  36. Williams, M. and P. Talbot: Design Features in Multiple Generations of Electronic Cigarette Atomizers; Int. J. Environ. Res. Public Health 16 (2019) 2904. DOI: 10.3390/ijerph16162904
  37. Cahours, X. and K. Prasad: A Review of Electronic Cigarette Use Behaviour Studies; Beitr. Tabakforsch. Int. 28 (2018) 81–92. DOI: 10.2478/cttr-2018-0009
  38. Action on Smoking and Health (ASH): ASH Fact Sheet: Use of Electronic Cigarettes (Vapourisers) Among Adults in Great Britain; 2017. Available at: https://www.zougla.gr/file.ashx?fid=2207534 (accessed April 29, 2020)
  39. Wadsworth, E., J. Neale, A. McNeill, and S.C. Hitchman: How and Why Do Smokers Start Using E-Cigarettes? Qualitative Study of Vapers in London, UK; Int. J. Environ. Res. Public Health 13 (2016) 661–674. DOI: 10.3390/ijerph13070661
  40. Weaver, S.R., J.W. Health, D.L Ashley, J. Huang, T.F. Pechacek, and M.P. Erikson: What are the Reasons that Smokers Reject ENDS? A National Probability Survey of U.S. Adult Smokers, 2017–2018; Drug Alcohol Depend. 211 (2020) 107855. DOI: 10.1016/j.drugalcdep.2020.107855
  41. Beauval, N., M. Verrièle, A. Garat, I. Fronval, R. Dusautoir, S. Anthérieu, G. Garçon, J.M. Lo-Guidice, D. Allorge, and N. Locoge: Influence of Puffing Conditions on the Carbonyl Composition of E-Cigarette Aerosols; Int. J. Hyg. Environ. Health 222 (2019) 136–146. DOI: 10.1016/j.ijheh.2018.08.015
  42. Farsalinos, K.E. and G. Gillman: Carbonyl Emissions in E-Cigarette Aerosol: A Systematic Review and Methodological Considerations; Front. Physiol. 8 (2018) 1119. DOI: 10.3389/fphys.2017.01119
  43. Flora, J.W., N. Meruva, C.B. Huang, C.T. Wilkinson, R. Ballentine, D.C. Smith, M.S. Werley, and W.J. McKinney: Characterization of Potential Impurities and Degradation Products in Electronic Cigarette Formulations and Aerosols; Regul. Toxicol. Pharmacol. 74 (2016) 1–11. DOI: 10.1016/j.yrtph.2015.11.009
  44. Goniewicz, M.L., J. Knysak, M. Gawron, L. Kosmider, A. Sobczak, J. Kurek, A. Prokopowicz, M. Jablonska-Czapla, C. Rosik-Dulewska, C. Havel, P. Jacob III, and N. Benowitz: Levels of Selected Carcinogens and Toxicants in Vapour from Electronic Cigarettes; Tob. Control 23 (2014) 133–139. DOI: 10.1136/tobaccocontrol-2012-050859
  45. Jensen, R.P., R.M. Strongin, and D.H. Peyton: Solvent Chemistry in the Electronic Cigarette Reaction Vessel; Sci. Rep. 7 (2017) 42549. DOI: 10.1038/srep42549
  46. Ogunwale, M.A., M. Li, M.V. Ramakrishnam Raju, Y. Chen, M.H. Nantz, D.J. Conklin, and X.A. Fu: Aldehyde Detection in Electronic Cigarette Aerosols; ACS Omega 2 (2017) 1207–1214. DOI: 10.1021/acsomega.6b00489
  47. Stephens, W.E.: Comparing the Cancer Potencies of Emissions from Vapourised Nicotine Products Including E-Cigarettes with Those of Tobacco Smoke; Tob. Control 27 (2018) 10–17. DOI: 10.1136/tobaccocontrol-2017-053808
  48. Farsalinos, K.E., G. Romagna, D. Tsiapras, S. Kyrzopoulos, and V. Voudris: Evaluation of Electronic Cigarette Use (Vaping) Topography and Estimation of Liquid Consumption: Implications for Research Protocol Standards Definition and for Public Health Authorities’ Regulation; Int. J. Environ. Res. Public Health 10 (2013) 2500–2514. DOI: 10.3390/ijerph10062500
  49. Kim, H., J. Lim, S.S. Buehler, M.C. Brinkman, N.M. Johnson, L. Wilson, K.S. Cross, and P.I. Clark: Role of Sweet and Other Flavours in Liking and Disliking of Electronic Cigarettes; Tob. Control 25 (2016) ii55–ii61. DOI: 10.1136/tobaccocontrol-2016-053221
  50. Laverty, A.A., C.I. Vardavas, and F.T. Filippidis: Design and Marketing Features Influencing Choice of E-Cigarettes and Tobacco in the EU; Eur. J. Public Health 26 (2016) 838–841. DOI: 10.1093/eurpub/ckw109
  51. Pullicin, A.J., H. Kim, M.C. Brinkman, S.S. Buehler, P.I. Clark, and J. Lim: Impacts of Nicotine and Flavoring on the Sensory Perception of E-cigarette Aerosol; Nicotine Tob. Res. 22 (2020) 806–813. DOI: 10.1093/ntr/ntz058
  52. Zare, S., M. Nemati, and Y. Zheng: A Systematic Review of Consumer Preference for E-Cigarette Attributes: Flavor, Nicotine Strength, and Type; PLoS One 13 (2018) e0194145. DOI: 10.1371/journal.pone.0194145
  53. Baweja, R., K.M. Curci, J. Yingst, S. Veldheer, S. Hrabovsky, S.J. Wilson, T.T. Nichols, T. Eissenberg, and J. Foulds: Views of Experienced Electronic Cigarette Users; Addict. Res. Theory 24 (2016) 80–88. DOI: 10.3109/16066359.2015.1077947
  54. Berg, C.J.: Preferred Flavors and Reasons for E-Cigarette Use and Discontinued Use Among Never, Current, and Former Smokers; Int. J. Public Health 61 (2016) 225–236. DOI: 10.1007/s00038-015-0764-x
  55. Russell, C., N. McKeganey, T. Dickson, and M. Nides: Changing Patterns of First E-Cigarette Flavor Used and Current Flavors Used by 20,836 Adult Frequent E-Cigarette Users in the USA; Harm Reduct. J. 15 (2018) 33. DOI: 10.1186/s12954-018-0238-6
  56. Chen, J.C., B. Das, E.L. Mead, and D.L.G. Borzekowski: Flavored E-cigarette Use and Cigarette Smoking Susceptibility Among Youth; Tob. Regul. Sci. 3 (2017) 68–80. DOI: 10.18001/TRS.3.1.7
  57. Audrain-McGovern, J., A.A. Strasser, and E.P. Wileyto: The Impact of Flavoring on the Rewarding and Reinforcing Value of E-Cigarettes with Nicotine Among Young Adult Smokers; Drug Alcohol Depend. 166 (2016) 263–267. DOI: 10.1016/j.drugalcdep.2016.06.030
  58. Krishnan-Sarin S., B.G. Green, G. Kong, D.A. Cavallo, P. Jatlow, R. Gueorguieva, E. Buta, and S.S. O’Malley: Studying the Interactive Effects of Menthol and Nicotine Among Youth: An Examination Using E-Cigarettes; Drug Alcohol Depend. 180 (2017) 193–199. DOI: 10.1016/j.drugalcdep.2017.07.044
  59. Action on Smoking and Health (ASH): Use of Electronic Cigarettes (Vapourisers) Among Adults in Great Britain; 2019. Available at: https://ash.org.uk/information-and-resources/fact-sheets/statistical/use-of-e-cigarettes-among-adults-in-great-britain-2019 (accessed April 29, 2020)
  60. Gravely, S., K.M. Cummings, D. Hammond, E. Lindblom, D.M. Smith, N. Martin, R. Loewen, R. Borland, A. Hyland, M.E. Thompson, C. Boudreau, K. Kasza, J. Ouimet, A.C.K. Quah, R.J. O’Connor, and G.T. Fong: The Association of E-Cigarette Flavors with Satisfaction, Enjoyment, and Trying to Quit or Stay Abstinent from Smoking Among Regular Adult Vapers from Canada and the United States: Findings from the 2018 ITC Four Country Smoking and Vaping Survey; Nicotine Tob. Res. 22 (2020) 1831–1841. DOI: 10.1093/ntr/ntaa095
  61. Institute for Global Tobacco Control: Country Laws Regulating E-Cigarettes: A Policy Scan; 2020. Available at: https://www.globaltobaccocontrol.org/e-cigarette_policyscan (accessed April 29, 2020)
  62. Bond, C.M. and A.R. Barry: Do the Benefits of Electronic Cigarettes Outweigh the Risks?; Can. J. Hosp. Pharm. 71 (2018) 44–47.
  63. Rambaran, K., S. Sakhamuri, and L. Pinto Pereira: E-Cigarettes: Banning Flavours is Better Than an Outright Ban; Lancet Respir. Med. 7 (2019) e37. DOI: 10.1016/S2213-2600(19)30359-5
  64. Strombotne, K., J. Buckell, and J.L. Sindelar: Do JUUL and E-Cigarette Flavours Change Risk Perceptions of Adolescents? Evidence from a National Survey; Tob. Control 30 (2020) 199–205. DOI: 10.1136/tobaccocontrol-2019-055394
  65. U.S. Food and Drug Administration (FDA) and Department of Health and Human Services (HHS): Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products; 2016. Available at: https://www.federalregister.gov/documents/2016/05/10/2016-10685/deeming-tobacco-products-to-be-subject-to-the-federal-food-drug-and-cosmetic-act-as-amended-by-the (accessed January 6 2021).
  66. U.S. Department of Health and Human Services (HHS), Food and Drug Administration (FDA) Center for Tobacco Products: Premarket Tobacco Product Applications for Electronic Nicotine Delivery Systems. Guidance for Industry; 2019. Available at: https://www.fda.gov/media/127853/download (accessed August 4, 2020)
  67. U.S. Food and Drug Administration (FDA): Section 907 of the Federal Food, Drug, and Cosmetic Act – Tobacco Product Standards; 2018. Available at: https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/section-907-federal-food-drug-and-cosmetic-act-tobacco-product-standards (accessed September 7, 2020)
  68. U.S. Food and Drug Administration (FDA): Modified Risk Tobacco Products; 2020. Available at: https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-tobacco-products (accessed January 25, 2021).
  69. The European Parliament and the Council of the European Union: Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the Approximation of the Laws, Regulations and Administrative Provisions of the Member States Concerning the Manufacture, Presentation and Sale of Tobacco and Related Products and Repealing Directive 2001/37/EC; Official Journal of the European Union L127 (2014) 1–38.
  70. European Commission: Restriction of Hazardous Substances in Electrical and Electronic Equipment (RoHS); 2017. Available at: https://ec.europa.eu/environment/waste/rohs_eee/index_en.htm (accessed January 6, 2021)
  71. European Agency for Safety and Health at Work (EUOSHA): Regulation (EC) No 1907/2006 - Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH); 2006. Available at: https://osha.europa.eu/en/legislation/directives/regulation-ec-no-1907-2006-of-the-european-parliament-and-of-the-council (accessed January 6 2021).
  72. Committee of Advertising Practice (ASA-CAP): Can E-Cigarettes Claim to be Healthy?; 2018. Available at: https://www.asa.org.uk/news/can-e-cigarettes-claim-to-be-healthy.html (accessed September 7 2020).
  73. U.S. Department of Health and Human Services (HHS), Food and Drug Administration (FDA) Center for Tobacco Products: Guidance for Industry Modified Risk Tobacco Product Applications. Draft Guidance; 2012.
  74. Government of Canada: Vaping Product Regulations; 2018. Available at: https://www.canada.ca/en/health-canada/services/smoking-tobacco/vaping/product-safety-regulation.html (accessed April 29, 2020)
  75. European Committee for Standardization (CEN): CEN TR 17236:2018. Electronic Cigarettes and E-Liquids – Constituents to be Measured in the Aerosol of Vaping Products; 2018. Available at: https://standards.cen.eu/dyn/www/f?p=204:110:0::::FSP_PROJECT,FSP_ORG_ID:66961,1958025&cs=1CB5A86D99D10CD6A32BE1C35C52F2D34 (accessed September 7, 2020)
  76. European Committee for Standardization (CEN): CEN/TS 17287:2019. Requirements and Test Methods for Electronic Cigarette Devices; 2019. Available at: https://standards.cen.eu/dyn/www/f?p=204:110:0::::FSP_PROJECT:65461&cs=11304D006B6DAFFEE8110B2710FD7478A (accessed September 7, 2020)
  77. International Organization for Standardization (ISO): ISO 20768:2018. Vapour Products – Routine Analytical Vaping Machine – Definitions and Standard Conditions; ISO, Geneva, Switzerland, 2018. Available at: https://www.iso.org/standard/69019.html (accessed September 7, 2020).
  78. International Organization for Standardization (ISO): ISO 20714:2019. E-Liquid – Determination of Nicotine, Propylene Glycol and Glycerol in Liquids Used in Electronic Nicotine Delivery Devices – Gas Chromatographic Method; 2019. Available at: https://www.iso.org/standard/68905.html (accessed September 7, 2020).
  79. Belushkin, M., M. Esposito, G. Jaccard, C. Jeannet, A. Korneliou, and D. Tafin Djoko: Role of Testing Standards in Smoke-Free Product Assessments; Regul. Toxicol. Pharmacol. 98 (2018) 1–8. DOI: 10.1016/j.yrtph.2018.06.021
  80. Chatham-Stephens, K., R. Law, E. Taylor, P. Melstrom, R. Bunnell, B. Wang, B. Apelberg, and J.G. Schier: Notes from the Field: Calls to Poison Centers for Exposures to Electronic Cigarettes – United States, September 2010-February 2014; MMWR Morb. Mortal. Wkly. Rep. 63 (2014) 292–293.
  81. McCague, Y.: Ocular Chemical Burns Secondary to Accidental Administration of E-Cigarette Liquid; Adv. Emerg. Nurs. J. 40 (2018) 104–109. DOI: 10.1097/TME.0000000000000183
  82. Jamison, A. and D. Lockington: Ocular Chemical Injury Secondary to Electronic Cigarette Liquid Misuse; JAMA Ophthalmol. 134 (2016) 1443. DOI: 10.1001/jamaophthalmol.2016.3651
  83. Brownson, E.G., C.M. Thompson, S. Goldsberry, H.J. Chong, J.B. Friedrich, T.N. Pham, S. Arbabi, G.J. Carrougher, and N.S. Gibran: Explosion Injuries from E-Cigarettes; N. Engl. J. Med. 375 (2016) 1400–1402. DOI: 10.1056/NEJMc1608478
  84. The European Parliament and the Council of the European Union: Directive 2014/30/EU of the European Parliament and of the Council of 26 February 2014 on the Harmonisation of the Laws of the Member States Relating to Electromagnetic Compatibility; Official Journal of the European Union L96 (2014) 79–106.
  85. The European Parliament and the Council of the European Union: Directive 2011/65/EU of the European Parliament and of the Council of 8 June 2011 on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment; Official Journal of the European Union L174 (2011) 88–110.
  86. The European Parliament and the Council of the European Union: Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on General Product Safety; Official Journal of the European Union L0095 (2001) 1–23.
  87. Costigan, S. and C. Meredith: An Approach to Ingredient Screening and Toxicological Risk Assessment of Flavours in E-Liquids; Regul. Toxicol. Pharmacol. 72 (2015) 361–369. DOI: 10.1016/j.yrtph.2015.05.018
  88. Costigan, S. and J. Lopez-Belmonte: An Approach to Allergy Risk Assessments for E-Liquid Ingredients; Regul. Toxicol. Pharmacol. 87 (2017) 1–8. DOI: 10.1016/j.yrtph.2017.04.003
  89. Iskandar, A.R., I. Gonzalez-Suarez, S. Majeed, D. Marescotti, S. Sewer, Y. Xiang, P. Leroy, E. Guedj, C. Mathis, J.P. Schaller, P. Vanscheeuwijck, S. Frentzel, F. Martin, N.V. Ivanov, M.C. Peitsch, and J. Hoeng: A Framework for In Vitro Systems Toxicology Assessment of E-Liquids; Toxicol. Mech. Methods 26 (2016) 392–416. DOI: 10.3109/15376516.2016.1170251
  90. American E-Liquid Manufacturing Standards Association: E-Liquid Manufacturing Standards; 2014. Available at: http://www.aemsa.org/wp-content/uploads/2014/02/AEMSA-Standards_Version-1-8.pdf (accessed September 7, 2020)
  91. Go, Y.Y., J.Y. Mun, S.-W. Chae, J. Chang, and J.-J. Song: Comparison Between In Vitro Toxicities of Tobacco- and Menthol-Flavored Electronic Cigarette Liquids on Human Middle Ear Epithelial Cells; Sci. Rep. 10 (2020) 2544. DOI: 10.1038/s41598-020-59290-y
  92. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT): Framework for Risk Assessment of Flavouring Compounds in Electronic Nicotine (and Non-Nicotine) Delivery Systems (E(N)NDS – E-Cigarettes); 2020. Available at: https://cot.food.gov.uk/sites/default/files/frameworkforriskassessingflavourings_0.pdf (accessed January 26, 2021)
  93. Farsalinos, K. and G. Lagoumintzis: Toxicity Classification of E-Cigarette Flavouring Compounds Based on European Union Regulation: Analysis of Findings from a Recent Study; Harm Reduct. J. 16 (2019) 48. DOI: 10.1186/s12954-019-0318-2
  94. Berman, M.S., G. Connolly, M.K. Cummings, M.V. Djordjevic, D.K. Hatsukami, J.E. Henningfield, M. Myers, R.J. O’Connor, M. Parascandola, V. Rees, J.M. Rice, and P.G. Shields: Providing a Science Base for the Evaluation of Tobacco Products; Tob. Regul. Sci. 1 (2015) 76–93. DOI: 10.18001/TRS.1.1.8
  95. Murphy, J., M. Gaça, F. Lowe, E. Minet, D. Breheny, K. Prasad, O. Camacho, I.M. Fearon, C. Liu, C. Wright, K. McAdam, and C. Proctor: Assessing Modified Risk Tobacco and Nicotine Products: Description of the Scientific Framework and Assessment of a Closed Modular Electronic Cigarette; Regul. Toxicol. Pharmacol. 90 (2017) 342–357. DOI: 10.1016/j.yrtph.2017.09.008
  96. Smith, M.R., B. Clark, F. Lüdicke, J.P. Schaller, P. Vanscheeuwijck, J. Hoeng, and M.C. Peitsch: Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the System and the Scientific Assessment Program; Regul. Toxicol. Pharmacol. 81, Suppl. 2 (2016) S17–S26. DOI: 10.1016/j.yrtph.2016.07.006
  97. Geiss, O., I. Bianchi, and J. Barerro-Morena: Correlation of Volatile Carbonyl Yields Emitted by E-Cigarettes with the Temperature of the Heating Coil and the Perceived Sensorial Quality of the Generated Vapours; Int. J. Hyg. Environ. Health 219 (2016) 268–277. DOI: 10.1016/j.ijheh.2016.01.004
  98. Etter, J.-F., E. Zäther, and S. Svensson: Analysis of Refill Liquids for Electronic Cigarettes; Addiction 108 (2013) 1671–1679. DOI: 10.1111/add.12235
  99. Kim, H.-J. and H.-S. Shin: Determination of Tobacco-Specific Nitrosamines in Replacement Liquids of Electronic Cigarettes by Liquid Chromatography-Tandem Mass Spectrometry; J. Chromatogr. A 1291 (2013) 48–55. DOI: 10.1016/j.chroma.2013.03.035
  100. Farsalinos, K.E., I.G. Gillman, M.S. Melvin, A.R. Paolantonio, W.J. Gardow, K.E. Humphries, S.E. Brown, K. Poulas, and V. Voudris: Nicotine Levels and Presence of Selected Tobacco-Derived Toxins in Tobacco Flavoured Electronic Cigarette Refill Liquids; Int. J. Environ. Res. Public Health 12 (2015) 3439–3452. DOI: 10.3390/ijerph120403439
  101. Lisko, J.G., H. Tran, S.B. Stanfill, B.C. Blount, and C.H. Watson: Chemical Composition and Evaluation of Nicotine, Tobacco Alkaloids, pH, and Selected Flavors in E-Eigarette Cartridges and Refill Solutions; Nicotine Tob. Res. 17 (2015) 1270–1278. DOI: 10.1093/ntr/ntu279
  102. Tayyarah, R. and G.A. Long: Comparison of Select Analytes in Aerosol from E-Cigarettes with Smoke from Conventional Cigarettes and with Ambient Air; Regul. Toxicol. Pharmacol. 70 (2014) 704–710. DOI: 10.1016/j.yrtph.2014.10.010
  103. U.S. Food and Drug Administration (FDA): Harmful and Potentially Harmful Constituents (HPHCs); Available at https://www.fda.gov/tobacco-products/products-ingredients-components/harmful-and-potentially-harmful-constituents-hphcs (accessed April 11, 2021)
  104. U.S. Federal Register: A Notice by the U.S. Food and Drug Administration (FDA): Harmful and Potentially Harmful Constituents in Tobacco Products; Established List, Proposed Additions; Request for Comments; Federal Register (2019) 84 FR 38032. Available at: https://www.federalregister.gov/documents/2019/08/05/2019-16658/harmful-and-potentially-harmful-constituents-in-tobacco-products-established-list-proposed-additions (accessed May 10, 2021)
  105. Zhao, T., S. Shu, Q. Guo, and Y. Zhu: Effects of Design Parameters and Puff Topography on Heating Coil Temperature and Mainstream Aerosols in Electronic Cigarettes; Atmos. Environ. 134 (2016) 61–69. DOI: 10.1016/j.atmosenv.2016.03.027
  106. Ward, A.M., R. Yaman, and J.O. Ebbert: Electronic Nicotine Delivery System Design and Aerosol Toxicants: A Systematic Review; PLoS One 15 (2020) e0234189. DOI: 10.1371/journal.pone.0234189
  107. Bansal, V. and K.H. Kim: Review on Quantitation Methods for Hazardous Pollutants Released by E-Cigarette (EC) Smoking; Trends Analyt. Chem. 78 (2016) 120–133. DOI: 10.1016/j.trac.2016.02.015
  108. Cheng, T.: Chemical Evaluation of Electronic Cigarettes; Tob. Control 23, Suppl. 2 (2014) ii11–ii17. DOI: 10.1136/tobaccocontrol-2013-051482
  109. Strongin, R.M.: E-Cigarette Chemistry and Analytical Detection; Annu. Rev. Anal. Chem. 12 (2019) 23–39. DOI: 10.1146/annurev-anchem-061318-115329
  110. Lauterbach, J.H. and M. Laugesen: Comparison of Toxicant Levels in Mainstream Aerosols Generated by Ruyan® Electronic Nicotine Delivery Systems (ENDS) and Conventional Cigarette Products; Poster #1861 presented at the Society of Toxicology 51st Annual Meeting & ToxExpo, San Francisco, CA, USA, March 2012.
  111. Lauterbach, J.H., M. Laugesen, and J.D. Ross: Suggested Protocol for Estimation of Harmful and Potentially Harmful Constituents in Mainstream Aerosols Generated by Electronic Nicotine Delivery Systems (ENDS); Poster #1860 presented at the Society of Toxicology 51st Annual Meeting & ToxExpo, San Francisco, CA, USA, March 2012.
  112. Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA): CORESTA Recommended Method No 81. Routine Analytical Machine for E-Cigarette Aerosol Generation and Collection – Definitions and Standard Conditions; 2015. Available at: https://www.coresta.org/sites/default/files/technical_documents/main/CRM_81.pdf (accessed April 29, 2020)
  113. Beauval, N., S. Antherieu, M. Soyez, N. Gengler, N. Grova, M. Howsam, E.M. Hardy, M. Fischer, B.M.R. Appenzeller, J.F. Goossens, D. Allorge, G. Garçon, J.M. Lo-Guidice, and A. Garat: Chemical Evaluation of Electronic Cigarettes: Multicomponent Analysis of Liquid Refills and Their Corresponding Aerosols; J. Anal. Toxicol. 41 (2017) 670–678. DOI: 10.1093/jat/bkx054
  114. Mallock, N., H.L. Trieu, M. Macziol, S. Malke, A. Katz, P. Laux, F. Henkler-Stephani, J. Hahn, C. Hutzler, and A. Luch: Trendy E-Cigarettes Enter Europe: Chemical Characterization of JUUL Pods and its Aerosols; Arch. Toxicol. 94 (2020) 1985–1994. DOI: 10.1007/s00204-020-02716-3
  115. Rudd, K., M. Stevenson, R. Wieczorek, J. Pani, E. Trelles-Sticken, O. Dethloff, L. Czekala, L. Simms, F. Buchanan, G. O’Connell, and T. Walele: Chemical Composition and In Vitro Toxicity Profile of a Pod-Based E-Cigarette Aerosol Compared to Cigarette Smoke; Appl. In Vitro Toxicol. 6 (2020) 11–41. DOI: 10.1089/aivt.2019.0015
  116. Belushkin, M., D. Tafin Djoko, M. Esposito, A. Korneliou, C. Jeannet, M. Lazzerini, and G. Jaccard: Selected Harmful and Potentially Harmful Constituents Levels in Commercial E-Cigarettes; Chem. Res. Toxicol. 33 (2020) 657–668. DOI: 10.1021/acs.chemrestox.9b00470
  117. Wagner, K.A., J.W. Flora, M.S. Melvin, K.C. Avery, R.M. Ballentine, A.P. Brown, and W.J. McKinney: An Evaluation of Electronic Cigarette Formulations and Aerosols for Harmful and Potentially Harmful Constituents (HPHCs) Typically Derived from Combustion; Regul. Toxicol. Pharmacol. 95 (2018) 153–160. DOI: 10.1016/j.yrtph.2018.03.012
  118. Qu, Y., K.-H. Kim, and J.-E. Szulejko: The Effect of Flavor Content in E-Liquids on E-Cigarette Emissions of Carbonyl Compounds; Environ. Res. 166 (2018) 324–333. DOI: 10.1016/j.envres.2018.06.013
  119. Vas, C.A., A. Porter, and K. McAdam: Acetoin is a Precursor to Diacetyl in E-Cigarette Liquids; Food Chem. Toxicol. 133 (2019) 110727. DOI: 10.1016/j.fct.2019.110727
  120. Olmedo, P., W. Goessler, S. Tanda, M. Grau-Perez, S. Jarmul, A. Aherrera, R. Chen, M. Hilpert, J.E. Cohen, A. Navas-Acien, and A.M. Rule: Metal Concentrations in E-Cigarette Liquid and Aerosol Samples: The Contribution of Metallic Coils; Environ. Health Perspect. 126 (2018) 027010. DOI: 10.1289/EHP2175
  121. Palazzolo, D.L., A.P. Crow, J.M. Nelson, and R.A. Johnson: Trace Metals Derived from Electronic Cigarette (ECIG) Generated Aerosol: Potential Problem of ECIG Devices That Contain Nickel; Front. Physiol. 7 (2017) 663. DOI: 10.3389/fphys.2016.00663
  122. Zervas, E., H. Matsouki, G. Kyriakopoulos, S. Poulopoulos, T. Ioannides, and P. Katsaounou: Transfer of Metals in the Liquids of Electronic Cigarettes; Inhal. Toxicol. 32 (2020) 240–248. DOI: 10.1080/08958378.2020.1776801
  123. Williams, M., A. Villarreal, K. Bozhilov, S. Lin, and P. Talbot: Metal and Silicate Particles Including Nano-particles Are Present in Electronic Cigarette Cartomizer Fluid and Aerosol; PLoS One 8 (2013) e57987. DOI: 10.1371/journal.pone.0057987
  124. Williams, M., A. To, K. Bozhilov and, P. Talbot: Strategies to Reduce Tin and Other Metals in Electronic Cigarette Aerosol; PLoS One 10 (2015) e0138933. DOI: 10.1371/journal.pone.0138933
  125. Williams, M., K. Bozhilov, S. Ghai and P. Talbot: Elements Including Metals in the Atomizer and Aerosol of Disposable Electronic Cigarettes and Electronic Hookahs; PLoS One 12 (2017) e0175430. DOI: 10.1371/journal.pone.0175430
  126. Williams, M., K.N. Bozhilov, and P. Talbot: Analysis of the Elements and Metals in Multiple Generations of Electronic Cigarette Atomizers; Environ. Res. 175 (2019) 156–166. DOI: 10.1016/j.envres.2019.05.014
  127. Beauval, N., M. Howsam, S. Antherieu, D. Allorge, M. Soyez, G. Garçon, J.F. Goossens, J.M. Lo-Guidice and, A. Garat: Trace Elements in E-Liquids – Development and Validation of an ICP-MS Method for the Analysis of Electronic Cigarette Refills; Regul. Toxicol. Pharmacol. 79 (2016) 144–148. DOI: 10.1016/j.yrtph.2016.03.024
  128. Kamilari, E., K. Farsalinos, K. Poulas, C.G. Kontoyannis, and M.G. Orkoula: Detection and Quantitative Determination of Heavy Metals in Electronic Cigarette Refill Liquids Using Total Reflection X-Ray Fluorescence Spectrometry; Food Chem. Toxicol. 116 (2018) 233–237. DOI: 10.1016/j.fct.2018.04.035
  129. Na, C.-J., S.-H. Jo, K.-H. Kim, J.-R. Sohn, and Y.-S. Son: The Transfer Characteristics of Heavy Metals in Electronic Cigarette Liquid; Environ. Res. 174 (2019) 152–159. DOI: 10.1016/j.envres.2019.04.025
  130. Zhao, D., A. Navas-Acien, V. Ilievski, V. Slavkovich, P. Olmedo, B. Adria-Mora, A. Domingo-Relloso, A. Aherrera, N.J. Kleiman, A.M. Rule, and M. Hilpert: Metal Concentrations in Electronic Cigarette Aerosol: Effect of Open-System and Closed-System Devices and Power Settings; Environ. Res. 174 (2019) 125–134. DOI: 10.1016/j.envres.2019.04.003
  131. Farsalinos, K.E., V. Voudris, and K. Poulas: Are Metals Emitted from Electronic Cigarettes a Reason for Health Concern? A Risk-Assessment Analysis of Currently Available Literature; Int. J. Environ. Res. Public Health 12 (2015) 5215–5232. DOI: 10.3390/ijerph120505215
  132. Fowles, J., T. Barreau, and N. Wu: Cancer and Non-Cancer Risk Concerns from Metals in Electronic Cigarette Liquids and Aerosols; Int. J. Environ. Res. Public Health 17 (2020) 2146. DOI: 10.3390/ijerph17062146
  133. Saliba, N.A., A. El Hellani, E. Honein, R. Salman, S. Talih, J. Zeaiter, and A. Shihadeh: Surface Chemistry of Electronic Cigarette Electrical Heating Coils: Effects of Metal Type on Propylene Glycol Thermal Decomposition; J. Anal. Appl. Pyrolysis 134 (2018) 520–525. DOI: 10.1016/j.jaap.2018.07.019
  134. Uchiyama, S., K. Ohta, Y. Inaba, and N. Kunugita: Determination of Carbonyl Compounds Generated from the E-Cigarette Using Coupled Silica Cartridges Impregnated with Hydroquinone and 2,4-Dinitrophenylhydrazine, Followed by High-Performance Liquid Chromatography; Anal. Sci. 29 (2013) 1219–1222. DOI: 10.2116/analsci.29.1219
  135. Farsalinos, K.E., K.A. Kistler, A. Pennington, A. Spyrou, D. Kouretas, and G. Gillman: Aldehyde Levels in E-Cigarette Aerosol: Findings from a Replication Study and from Use of a New-Generation Device; Food Chem. Toxicol. 111 (2018) 64–70. DOI: 10.1016/j.fct.2017.11.002
  136. Gillman, I.G., K. Kistler, E. Stewart, and A.R. Paolantonio: Effect of Variable Power Levels on the Yield of Total Aerosol Mass and Formation of Aldehydes in E-Cigarette Aerosols; Regul. Toxicol. Pharmacol. 75 (2016) 58–65. DOI: 10.1016/j.yrtph.2015.12.019
  137. Kosmider, L., C.F. Kimber, J. Kurek, O. Corcoran, and L.E. Dawkins: Compensatory Puffing with Lower Nicotine Concentration E-Liquids Increases Carbonyl Exposure in E-Cigarette Aerosols; Nicotine Tob. Res. 20 (2018) 998–1003. DOI: 10.1093/ntr/ntx162
  138. Leventhal, A.M., D.R. Madden, N. Peraza, S.J. Schiff, L. Lebovitz, L. Whitted, J. Barrington-Trimis, T.B. Mason, M.K. Anderson, and A.P. Tackett: Effect of Exposure to E-Cigarettes with Salt vs Free-Base Nicotine on the Appeal and Sensory Experience of Vaping: A Randomized Clinical Trial; JAMA Netw. Open. 4 (2021) e2032757. DOI: 10.1001/jamanetworkopen.2020.32757
  139. Ebajemito, J.K., M. McEwan, N. Gale, O.M. Camacho, G. Hardie, and C.J. Proctor: A Randomised Controlled Single-Centre Open-Label Pharmacokinetic Study to Examine Various Approaches of Nicotine Delivery Using Electronic Cigarettes; Sci. Rep. 10 (2020) 19980. DOI: 10.1038/s41598-020-76610-4
  140. O’Connell, G., J.D. Pritchard, C. Prue, J. Thompson, T. Verron, D. Graff, and T.A. Walele: A Randomised, Open-Label, Cross-Over Clinical Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes with Nicotine Salt Formulations in US Adult Smokers; Intern. Emerg. Med. 14 (2019) 853–861. DOI: 10.1007/s11739-019-02025-3
  141. Talih, S., R. Salman, R. El-Hage, N. Karaoghlanian, A. El-Hellani, N. Saliba, and A. Shihadeh: Effect of Free-Base and Protonated Nicotine on Nicotine Yield from Electronic Cigarettes with Varying Power and Liquid Vehicle; Sci. Rep. 10 (2020) 16263. DOI: 10.1038/s41598-020-73385-6
  142. Harvanko, A.M., C.M. Havel, P. Jacob III, and N.L. Benowitz: Characterization of Nicotine Salts in 23 Electronic Cigarette Refill Liquids; Nicotine Tob. Res. 22 (2020) 1239–1243. DOI: 10.1093/ntr/ntz232
  143. Moldoveanu, S.C.: Pyrolysis of Organic Molecules with Applications to Health and Environmental Issues; in: Techniques and Instrumentation in Analytical Chemistry, Vol 28, Elsevier Science, Amsterdam, The Netherlands, 2010, pp. 471–526.
  144. Pankow, J.F., K. Kim, K.J. McWhirter, W. Luo, J.O. Escobedo, R.M. Strongin, A.K. Duell, and D.H. Peyton: Benzene Formation in Electronic Cigarettes; PLoS One 12 (2017) e0173055. DOI: 10.1371/journal.pone.0173055
  145. Cao, S., C. Yang, Y. Gan, and Z. Lu: The Health Effects of Passive Smoking: An Overview of Systematic Reviews Based on Observational Epidemiological Evidence; PLoS One 10 (2015) e0139907. DOI: 10.1371/journal.pone.0139907
  146. Li, L., Y. Lin, T. Xia, and Y. Zhu: Effects of Electronic Cigarettes on Indoor Air Quality and Health; Ann. Rev. Public Health 41 (2020) 363–380. DOI: 10.1146/annurev-publhealth-040119-094043
  147. Chen, R., A. Aherrera, C. Isichei, P. Olmedo, S. Jarmul, J.E. Cohen, A. Navas-Acien, and A.M. Rule: Assessment of Indoor Air Quality at an Electronic Cigarette (Vaping) Convention; J. Expo. Sci. Environ. Epidemiol. 28 (2018) 522–529. DOI: 10.1038/s41370-017-0005-x
  148. Martuzevicius, D., T. Prasauskas, A. Setyan, G. O’Connell, X. Cahours, R. Julien, and S. Colard: Characterization of the Spatial and Temporal Dispersion Differences Between Exhaled E-Cigarette Mist and Cigarette Smoke; Nicotine Tob. Res. 21 (2019) 1371–1377. DOI: 10.1093/ntr/nty121
  149. Czogala, J., M.L. Goniewicz, B. Fidelus, W. Zielinska-Danch, M.J. Travers, and A. Sobczak: Secondhand Exposure to Vapors from Electronic Cigarettes; Nicotine Tob. Res. 16 (2014) 655–662. DOI: 10.1093/ntr/ntt203
  150. Klepeis, N.E., J. Bellettiere, S.C. Hughes, B. Nguyen, V. Berardi, S. Liles, S. Obayashi, C.R. Hofstetter, E. Blumberg, and M.F. Hovell: Fine Particles in Homes of Predominantly Low-Income Families with Children and Smokers: Key Physical and Behavioral Determinants to Inform Indoor-Air-Quality Interventions; PLoS One 12 (2017) e0177718. DOI: 10.1371/journal.pone.0177718
  151. Bals, R., J. Boyd, S. Esposito, R. Foronjy, P.S. Hiemstra, C.A. Jiménez-Ruiz, P. Katsaounou, A. Lindberg, C. Metz, W. Schober, A. Spira, and F. Blasi: Electronic Cigarettes: A Task Force Report from the European Respiratory Society; Eur. Respir. J. 53 (2019) 1801151. DOI: 10.1183/13993003.01151-2018
  152. Cancer Research UK: Cancer Research UK Briefing: Electronic Cigarettes; 2016. Available at: https://www.cancerresearchuk.org/sites/default/files/e-cigarette_briefing_nov_2016_final.pdf (accessed January 26, 2021)
  153. Public Health England: Use of E-Cigarettes in Public Places and Workplaces. Advice to Inform Evidence-based Policy Making; 2016. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/768952/PHE-advice-on-use-of-e-cigarettes-in-public-places-and-workplaces.PDF (accessed January 26, 2021)
  154. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT): Statement on the Potential Toxicological Risks from Electronic Nicotine (and Non-Nicotine) Delivery Systems (E(N)NDS – E-Cigarettes); 2020. Available at: https://cot.food.gov.uk/sites/default/files/2020-09/COTE(N)NDSstatement2020-04.pdf (accessed January 26, 2021)
  155. Raunio, H.: In Silico Toxicology – Non-Testing Methods; Front. Pharmacol. 2 (2011) 33. DOI: 10.3389/fphar.2011.00033
  156. Zarini, D., A. Sangion, E. Ferri, E. Caruso, S. Zucchi, A. Orro, and E. Papa: Are In Silico Approaches Applicable as a First Step for the Prediction of E-Liquid Toxicity in E-Cigarettes?; Chem. Res. Toxicol. 33 (2020) 2381–2389. DOI: 10.1021/acs.chemrestox.0c00136
  157. Merecz-Sadowska, A., P. Sitarek, H. Zielinska-Blizniewska, K. Malinowska, K. Zajdel, L. Zakonnik, and R. Zajdel: A Summary of In Vitro and In Vivo Studies Evaluating the Impact of E-Cigarette Exposure on Living Organisms and the Environment; Int. J. Mol. Sci. 21 (2020) 652. DOI: 10.3390/ijms21020652
  158. Avila, A.M., I. Bebenek, J.A. Bonzo, T. Bourcier, K.L. Davis Bruno, D.B. Carlson, J. Dubinion, I. Elayan, W. Harrouk, S.L. Lee, D.L. Mendrick, J.C. Merrill, J. Peretz, E. Place, M. Saulnier, R.L. Wange, J. Yao, D. Zhao, and P.C. Brown: An FDA/CDER Perspective on Nonclinical Testing Strategies: Classical Toxicology Approaches and New Approach Methodologies (NAMs); Regul. Toxicol. Pharmacol. 114 (2020) 104662. DOI: 10.1016/j.yrtph.2020.104662
  159. European Chemicals Agency: In Vitro Methods; 2020. Available at: https://echa.europa.eu/support/registration/how-to-avoid-unnecessary-testing-on-animals/in-vitro-methods (accessed January 6, 2021).
  160. Wan, J., M.D. Johnson, J. Schilz, M.V. Djordjevic, J.R. Rice, and P.G. Shields: Evaluation of In Vitro Assays for Assessing the Toxicity of Cigarette Smoke and Smokeless Tobacco; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3263–3304. DOI: 10.1158/1055-9965.EPI-09-0965
  161. Czekala, L., L. Simms, M. Stevenson, N. Tschierske, A.G. Maione, and T. Walele: Toxicological Comparison of Cigarette Smoke and E-Cigarette Aerosol Using a 3D In Vitro Human Respiratory Model; Regul. Toxicol. Pharmacol. 103 (2019) 314–324. DOI: 10.1016/j.yrtph.2019.01.036
  162. Iskandar, A.R., C. Mathis, F. Martin, P. Leroy, A. Sewer, S. Majeed, D. Kuehn, K. Trivedi, D. Grandolfo, M. Cabanski, E. Guedj, C. Merg, S. Frentzel, N.V. Ivanov, M.C. Peitsch and J. Hoeng: 3-D Nasal Cultures: Systems Toxicological Assessment of a Candidate Modified-Risk Tobacco Product; ALTEX 34 (2017) 23–48. DOI: 10.14573/altex.1605041
  163. Breheny, D., D. Thorne, A. Baxter, S. Bozhilova, T. Jaunky, S. Santopietro, M. Taylor, A. Terry, and M. Gaça: The In Vitro Assessment of a Novel Vaping Technology; Toxicol. Rep. 7 (2020) 1145–1156. DOI: 10.1016/j.toxrep.2020.08.016
  164. Wang, G., W. Liu, and W. Song: Toxicity Assessment of Electronic Cigarettes; Inhal. Toxicol. 31 (2019) 259–273. DOI: 10.1080/08958378.2019.1671558
  165. Breheny, D., O. Oke, K. Pant, and M. Gaça: Comparative Tumour Promotion Assessment of E-Cigarette and Cigarettes Using the In Vitro Bhas 42 Cell Transformation Assay; Environ. Mol. Mutagen. 58 (2017) 190–198. DOI: 10.1002/em.22091
  166. Thorne, D., I. Crooks, M. Hollings, A. Seymour, C. Meredith, and M. Gaça: The Mutagenic Assessment of an Electronic-Cigarette and Reference Cigarette Smoke Using the Ames Assay in Strains TA98 and TA100; Mutat. Res. 812 (2016) 29–38. DOI: 10.1016/j.mrgentox.2016.10.005
  167. Thorne, D., M. Hollings, A. Seymour, J. Adamson, A. Dalrymple, M. Ballantyne, and M. Gaca: Extreme Testing of Undiluted E-Cigarette Aerosol In Vitro Using an Ames Air-Agar-Interface Technique; Mutat. Res. Genet. Toxicol. Environ. Mutagen. 828 (2018) 46–54. DOI: 10.1016/j.mrgentox.2018.01.008
  168. Azzopardi, D., K. Patel, T. Jaunky, S. Santopietro, O.M. Camacho, J. McAughey, and M. Gaça: Electronic Cigarette Aerosol Induces Significantly Less Cytotoxicity Than Tobacco Smoke; Toxicol. Mech. Methods 26 (2016) 477–491. DOI: 10.1080/15376516.2016.1217112
  169. Bishop, E., L. Haswell, J. Adamson, S. Costigan, D. Thorne, and M. Gaça: An Approach to Testing Undiluted E-Cigarette Aerosol In Vitro Using 3D Reconstituted Human Airway Epithelium; Toxicol. In Vitro 54 (2019) 391–401. DOI: 10.1016/j.tiv.2018.01.010
  170. Makwana, O., H. Flockton, G.A. Smith, G.P. Watters, R. Nisar, and W. Fields: Mechanisms of Whole Smoke Conditioned Media Induced Cytotoxicity to Human Aortic Endothelial Cells; Toxicol. In Vitro 58 (2019) 239–244. DOI: 10.1016/j.tiv.2019.03.011
  171. Neilson, L., C. Mankus, D. Thorne, G. Jackson, J. DeBay, and C. Meredith: Development of an In Vitro Cytotoxicity Model for Aerosol Exposure Using 3D Reconstructed Human Airway Tissue; Application for Assessment of E-Cigarette Aerosol; Toxicol. In Vitro 29 (2015) 1952–1962. DOI: 10.1016/j.tiv.2015.05.018
  172. Thorne, D., S. Larard, A. Baxter, C. Meredith, and M. Gaça: The Comparative In Vitro Assessment of E-Cigarette and Cigarette Smoke Aerosols Using the γH2AX Assay and Applied Dose Measurements; Toxicol. Lett. 265 (2017) 170–178. DOI: 10.1016/j.toxlet.2016.12.006
  173. Thorne, D., R. Leverette, D. Breheny, M. Lloyd, S. McEnaney, J. Whitwell, J. Clements, B. Bombick, and M. Gaça: Genotoxicity Evaluation of Tobacco and Nicotine Delivery Products: Part One. Mouse Lymphoma Assay; Food Chem. Toxicol. 132 (2019) 110584. DOI: 10.1016/j.fct.2019.110584
  174. Thorne, D., R. Leverette, D. Breheny, M. Lloyd, S. McEnaney, J. Whitwell, J. Clements, B. Bombick, and M. Gaça: Genotoxicity Evaluation of Tobacco and Nicotine Delivery Products: Part Two. In Vitro Micronucleus Assay; Food Chem. Toxicol. 132 (2019) 110546. DOI: 10.1016/j.fct.2019.05.054
  175. Ito, S., M. Taylor, S. Mori, D. Thorne, T. Nishino, D. Breheny, M. Gaça, K. Yoshino, and C. Proctor: An Inter-Laboratory In Vitro Assessment of Cigarettes and Next Generation Nicotine Delivery Products; Toxicol. Lett. 315 (2019) 14–22. DOI: 10.1016/j.toxlet.2019.08.004
  176. Taylor, M., T. Carr, O. Oke, T. Jaunky, D. Breheny, and F. Lowe: E-Cigarette Aerosols Induce Lower Oxidative Stress In Vitro When Compared to Tobacco Smoke; Toxicol. Mech. Methods 6 (2016) 445–467. DOI: 10.1080/15376516.2016.1222473
  177. Taylor, M., T. Jaunky, K. Hewitt, D. Breheny, F. Lowe, I.M. Fearon, and M. Gaça: A Comparative Assessment of E-Cigarette Aerosols and Cigarette Smoke on In Vitro Endothelial Cell Migration; Toxicol. Lett. 277 (2017) 123–128. DOI: 10.1016/j.toxlet.2017.06.001
  178. Farsalinos, K.E. and R. Polosa: Safety Evaluation and Risk Assessment of Electronic Cigarettes as Tobacco Cigarette Substitutes: A Systematic Review; Ther. Adv. Drug Saf. 5 (2014) 67–86. DOI: 10.1177/2042098614524430
  179. Public Health England – Committee on Toxicity (COT): E-Cigarettes Likely to Reduce Harm to Health for Smokers but are not Entirely Risk-Free; 2020. Available at: https://phe-newsroom.prgloo.com/news/e-cigarettes-likely-to-reduce-harm-to-health-for-smokers-but-are-not-entirely-risk-free (accessed January 26, 2021)
  180. Banerjee, A., L.E. Haswell, A. Baxter, A. Parmar, D. Azzopardi, S. Corke, D. Thorne, J. Adamson, J. Mushonganono, M.D. Gaça, and E. Minet: Differential Gene Expression Using RNA Sequencing Profiling in a Reconstituted Airway Epithelium Exposed to Conventional Cigarette Smoke or Electronic Cigarette Aerosols; Appl. In Vitro Toxicol. 3 (2017) 84–98. DOI: 10.1089/aivt.2016.0024
  181. Haswell, L.D., A. Baxter, A. Banerjee, I. Verrastro, J. Mushonganono, J. Adamson, D. Thorne, M. Gaça, and E. Minet: Reduced Biological Effect of E-Cigarette Aerosol Compared to Cigarette Smoke Evaluated In Vitro Using Normalized Nicotine Dose and RNA-Seq-Based Toxicogenomics; Sci. Rep. 7 (2017) 888. DOI: 10.1038/s41598-017-00852-y
  182. Marescotti, D., C. Mathis, V. Belcastro, P. Leroy, S. Acali, F. Martin, R. Dulize, D. Bornand, D. Peric, E. Guedj, L. Ortega Torres, M. Biasioli, M. Fuhrimann, E. Fernandes, F. Frauendorfer, I. Gonzalez Suarez, D. Sciuscio, N.V. Ivanov, M.C. Peitsch, and J. Hoeng: Systems Toxicology Assessment of a Representative E-Liquid Formulation Using Human Primary Bronchial Epithelial Cells; Toxicol. Rep. 7 (2019) 67–80. DOI: 10.1016/j.toxrep.2019.11.016
  183. Titz, B., J. Szostak, A. Sewer, B. Phillips, C. Nury, T. Schneider, S. Dijon, O. Lavrynenko, A. Elamin, E. Guedj, E. Tsin Wong, S. Lebrun, G. Vuillaume, A. Kondylis, S. Gubian, S. Cano, P. Leroy, B. Keppler, N.V. Ivanov, P. Vanscheeuwijck, F. Martin, M.C. Peitsch, and J. Hoeng: Multi-Omics Systems Toxicology Study of Mouse Lung Assessing the Effects of Aerosols from Two Heat-Not-Burn Tobacco Products and Cigarette Smoke; Comput. Struct. Biotechnol. J. 18 (2020) 1056–1073. DOI: 10.1016/j.csbj.2020.04.011
  184. Slob, W., L.G. Soeteman-Hernández, W. Bil, Y.C.M. Staal, W.E. Stephens, and R. Talhout: A Method for Comparing the Impact on Carcinogenicity of Tobacco Products: A Case Study on Heated Tobacco Versus Cigarettes; Risk Anal. 40 (2020) 1355–1366. DOI: 10.1111/risa.13482
  185. U.S. Department of Health and Human Services (DHHS): The Health Consequences of Smoking: A Report of the Surgeon General; Centers for Disease Control and Prevention, Atlanta, GA, USA, 2004. Available at: https://www.ncbi.nlm.nih.gov/books/NBK44695/ (accessed May 12, 2021)
  186. El Dib, R., E.A. Suzumura, E.A. Akl, H. Gomaa, A. Agarwal, Y. Chang, M. Prasad, V. Ashoorion, D. Heels-Ansdell, W. Maziak, and G. Guyatt: Electronic Nicotine Delivery Systems and/or Electronic Non-nicotine Delivery Systems for Tobacco Smoking Cessation or Reduction: A Systematic Review and Meta-Analysis; BMJ Open 7 (2017) e012680. DOI: 10.1136/bmjopen-2016-012680
  187. Hartmann-Boyce, J., H. McRobbie, C. Bullen, R. Begh, L.F. Stead, and P. Hajek: Electronic Cigarettes for Smoking Cessation; Cochrane Database Syst. Rev. 9 (2016) CD010216. DOI: 10.1002/14651858.CD010216.pub3
  188. Kalkhoran, S. and S.A. Glantz: E-Cigarettes and Smoking Cessation in Real-World and Clinical Settings: A Systematic Review and Meta-Analysis; Lancet Respir. Med. 4 (2016) 116–128. DOI: 10.1016/S2213-2600(15)00521-4
  189. Simonavicius, E., A. McNeil, D. Arnott, and L.S. Brose: What Factors are Associated with Current Smokers Using or Stopping E-Cigarette Use?; Drug Alcohol Depend. 173 (2017) 139–143. DOI: 10.1016/j.drugalcdep.2017.01.002
  190. Fearon, I.M., A.C. Eldridge, N. Gale, M. McEwan, M.F. Stiles, and E.K. Round: Nicotine Pharmacokinetics of Electronic Cigarettes: A Review of the Literature; Regul. Toxicol. Pharmacol. 100 (2018) 25–34. DOI: 10.1016/j.yrtph.2018.09.004
  191. Armitage, A., C. Dollery, T. Houseman, E. Kohner, P. Lewis, and D. Turner: Absorption of Nicotine from Small Cigars; Clin. Pharmacol. Ther. 23 (1978) 143–151. DOI: 10.1002/cpt1978232143
  192. Armitage, A.K., J. Alexander, R. Hopkins, and C. Ward: Evaluation of a Low to Middle Tar/Medium Nicotine Cigarette Designed to Maintain Nicotine Delivery to the Smoker; Psychopharmacology 96 (1988) 447–453. DOI: 10.1007/BF02180022
  193. Armitage, A. and D. Turner: Absorption of Nicotine in Cigarette and Cigar Smoke Through the Oral Mucosa; Nature 226 (1970) 1231–1232. DOI: 10.1038/2261231a0
  194. Benowitz, N. and P. Jacob III: Daily Intake of Nicotine During Cigarette Smoking; Clin. Pharmacol. Ther. 35 (1984) 499–504. DOI: 10.1038/clpt.1984.67
  195. Digard, H., C. Proctor, A. Kulasekaran, U. Malmqvist, and A. Richter: Determination of Nicotine Absorption from Multiple Tobacco Products and Nicotine Gum; Nicotine Tob. Res. 15 (2013) 255–261. DOI: 10.1093/ntr/nts123
  196. Stiles, M.F., L.R. Campbell, D.W. Graff, B.A. Jones, R.V. Fant, and J.E. Henningfield: Pharmacodynamic and Pharmacokinetic Assessment of Electronic Cigarettes, Combustible Cigarettes, and Nicotine Gum: Implications for Abuse Liability; Psychopharmacology 234 (2017) 2643–2655. DOI: 10.1007/s00213-017-4665-y
  197. Stiles, M.F., L.R. Campbell, T. Jin, D.W. Graff, R.V. Fant, and J.E. Henningfield: Assessment of the Abuse Liability of Three Menthol Vuse Solo Electronic Cigarettes Relative to Combustible Cigarettes and Nicotine Gum; Psychopharmacology 235 (2018) 2077–2086. DOI: 10.1007/s00213-018-4904-x
  198. Bullen, C., H. McRobbie, S. Thornley, M. Glover, R. Lin, and M. Laugesen: Effect of an Electronic Nicotine Delivery Device (E Cigarette) on Desire to Smoke and Withdrawal, User Preferences and Nicotine Delivery: Randomised Cross-Over Trial; Tob. Control 19 (2010) 98–103. DOI: 10.1136/tc.2009.031567
  199. Hansson, A., T. Rasmussen, and H. Kraiczi: Single-Dose and Multiple-Dose Pharmacokinetics of Nicotine 6 mg Gum; Nicotine Tob. Res. 19 (2017) 477–483. DOI: 10.1093/ntr/ntw211
  200. Sukhija, M., R. Srivastava and A. Kaushik: Pharmacokinetic Characterization of Three Novel 4-mg Nicotine Lozenges; Int. J. Clin. Pharmacol. Ther. 56 (2018) 113–119. DOI: 10.5414/CP203097
  201. Farsalinos K.E., A. Spyrou, K. Tsimopoulou, C. Stefopoulos, G. Romagna, and V. Voudris: Nicotine Absorption from Electronic Cigarette Use: Comparison Between First and New-Generation Devices; Sci. Rep. 4 (2014) 4133. DOI: 10.1038/srep04133
  202. Nides, M.N., S.J. Leischow, M. Bhatter, and M. Simmons: Nicotine Blood Levels and Short-Term Smoking Reduction with an Electronic Nicotine Delivery System; Am. J. Health Behav. 38 (2014) 265–274. DOI: 10.5993/AJHB.38.2.12
  203. Walele, T., T. Sharma, R. Savioz, C. Martin, and J. Williams: A Randomised, Crossover Study on an Electronic Vapour Product, a Nicotine Inhalator and a Conventional Cigarette. Part A: Pharmacokinetics; Regul. Toxicol. Pharmacol. 74 (2016) 187–192. DOI: 10.1016/j.yrtph.2015.12.003
  204. St. Helen, G., C. Havel, D.A. Dempsey, P. Jacob III, and N.L. Benowitz: Nicotine Delivery, Retention and Pharmacokinetics From Various Electronic Cigarettes; Addiction 111 (2016) 535–544. DOI: 10.1111/add.13183
  205. Vansickel, A.R. and T. Eissenberg: Electronic Cigarettes: Effective Nicotine Delivery After Acute Administration; Nicotine Tob. Res. 15 (2013) 267–270. DOI: 10.1093/ntr/ntr316
  206. Wagener, T.L., E.L. Floyd, I. Stepanov, L.M. Driskill, S.G. Frank, E. Meier, E.L. Leavens, A.P. Tackett, N. Molina, and L. Queimado: Have Combustible Cigarettes Met Their Match? The Nicotine Delivery Profiles and Harmful Constituent Exposures of Second-Generation and Third-Generation Electronic Cigarette Users; Tob. Control 26 (2017) e23–e28. DOI: 10.1136/tobaccocontrol-2016-053041
  207. Hajek, P., K. Pittaccio, F. Pesola, K. Myers Smith, A. Phillips-Waller, and D. Przulj: Nicotine Delivery and Users’ Reactions to Juul Compared with Cigarettes and Other E-Cigarette Products; Addiction 115 (2020) 1141–1148. DOI: 10.1111/add.14936
  208. Ramôa, C.P., M.M. Hiler, T.R. Spindle, A.A. Lopez, N. Karaoghlanian, T. Lipato, A.B. Breland, A. Shihadeh, and T. Eissenberg: Electronic Cigarette Nicotine Delivery Can Exceed That of Combustible Cigarettes: A Preliminary Report; Tob. Control 25 (2016) e6–9. DOI: 10.1136/tobaccocontrol-2015-052447
  209. Fearon, I.M., A. Eldridge, N. Gale, C.J. Shepperd, M. McEwan, O.M. Camacho, M. Nides, K. McAdam, and C.J. Proctor: E-Cigarette Nicotine Delivery: Data and Learnings From Pharmacokinetic Studies; Am. J. Health Behav. 41 (2017) 16–32. DOI: 10.5993/ajhb.41.1.2
  210. Hajek, P., M.L. Goniewicz, A. Phillips, K. Myers Smith, O. West, and H. McRobbie: Nicotine Intake from Electronic Cigarettes on Initial Use and After 4 Weeks of Regular Use; Nicotine Tob. Res. 17 (2015) 175–179. DOI: 10.1093/ntr/ntu153
  211. Cox, S., L. Dawkins, J. Doshi, and J. Cameron: Effects of E-Cigarettes Versus Nicotine Replacement Therapy on Short-Term Smoking Abstinence When Delivered at a Community Pharmacy; Addict. Behav. Rep. 10 (2019) 100202. DOI: 10.1016/j.abrep.2019.100202
  212. Hajek, P., A. Phillips-Waller, D. Przulj, F. Pesola, K. Myers Smith, N. Bisal, J. Li, S. Parrott, P. Sasieni, L. Dawkins, L. Ross, M. Goniewicz, Q. Wu, and H.J. McRobbie: A Randomized Trial of E-Cigarettes Versus Nicotine-Replacement Therapy; N. Engl. J. Med. 380 (2019) 629–637. DOI: 10.1056/NEJMoa1808779
  213. Chang, C.M., S.H. Edwards, A. Arab, A.Y. Del Valle-Pinero, L. Yang, and D.K. Hatsukami: Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop; Cancer Epidemiol. Biomarkers Prev. 26 (2017) 291–302. DOI: 10.1158/1055-9965.EPI-16-0675
  214. Czoli, C.D., G.T. Fong, M.J. Goniewicz, and D. Hammond: Biomarkers of Exposure Among “Dual Users” of Tobacco Cigarettes and Electronic Cigarettes in Canada; Nicotine Tob. Res. 21 (2019) 1259–1266. DOI: 10.1093/ntr/nty174
  215. Goniewicz, M.L., M. Gawron, D.M. Smith, M. Peng, P. Jacob III, and N.L. Benowitz: Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study; Nicotine Tob. Res. 19 (2017) 160–167. DOI: 10.1093/ntr/ntw160
  216. Lorkiewicz, P., D.W. Riggs, R.J. Keith, D.J. Conklin, Z. Xie, S. Sutaria, B. Lynch, S. Srivastava, and A. Bhatnagar: Comparison of Urinary Biomarkers of Exposure in Humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco; Nicotine Tob. Res. 21 (2019) 1228–1238. DOI: 10.1093/ntr/nty089
  217. McRobbie, H., A. Phillips, M.L. Goniewicz, K.M. Smith, O. Knight-West, D. Przulj, and P. Hajek: Effects of Switching to Electronic Cigarettes With and Without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and Acrolein; Cancer Prev. Res. 8 (2015) 873–878. DOI: 10.1158/1940-6207.CAPR-15-0058
  218. Aherrera, A., P. Olmedo, M. Grau-Perez, S. Tanda, W. Goessler, S. Jarmul, R. Chen, J.E. Cohen, A.M. Rule, and A. Navas-Acien: The Association of E-Cigarette Use with Exposure to Nickel and Chromium: A Preliminary Study of Non-Invasive Biomarkers; Environ. Res. 159 (2017) 313–320. DOI: 10.1016/j.envres.2017.08.014
  219. Goniewicz, M.L., D.M. Smith, K.C. Edwards, B.C. Blount, K.L. Caldwell, J. Feng, L. Wang, C. Christensen, B. Ambrose, N. Borek, D. van Bemmel, K. Konkel, G. Erives, C.A. Stanton, E. Lambert, H.L. Kimmel, D. Hatsukami, S.S. Hecht, R.S. Niaura, M. Travers, C. Lawrence, and A.J. Hyland: Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes; JAMA Netw. Open 1 (2018) e185937. DOI: 10.1001/jamanetworkopen.2018.5937
  220. Polosa, R., J.B. Morjaria, P. Caponnetto, U. Prosperini, C. Russo, A. Pennisi, and C.M. Bruno: Evidence for Harm Reduction in COPD Smokers Who Switch to Electronic Cigarettes; Respir. Res. 17 (2016) 166. DOI: 10.1186/s12931-016-0481-x
  221. Shahab, L., M.L. Goniewicz, B.C. Blount, J. Brown, A. McNeill, K.U. Alwis, J. Feng, L. Wang, and R. West: Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-Sectional Study; Ann. Intern. Med.166 (2017) 390–400. DOI: 10.7326/M16-1107
  222. Sakamaki-Ching, S., M. Williams, M. Hua, J. Li, S.M. Bates, A.N. Robinson, T.W. Lyons, M.L. Goniewicz, and P. Talbot: Correlation Between Biomarkers of Exposure, Effect and Potential Harm in the Urine of Electronic Cigarette Users; BMJ Open Respir. Res. 7 (2020) e000452. DOI: 10.1136/bmjresp-2019-000452
  223. Round, E.K., P. Chen, A.K. Taylor, and E. Schmidt: Biomarkers of Tobacco Exposure Decrease After Smokers Switch to an E-Cigarette or Nicotine Gum; Nicotine Tob. Res. 21 (2019) 1239–1247. DOI: 10.1093/ntr/nty140
  224. Walele, T., J. Bush, A. Koch, R. Savioz, C. Martin, and G. O’Connell: Evaluation of the Safety Profile of an Electronic Vapour Product Used for Two Years by Smokers in a Real-life Setting; Regul. Toxicol. Pharmacol. 92 (2018) 226–238. DOI: 10.1016/j.yrtph.2017.12.010
  225. Cravo, A.S., J. Bush, G. Sharma, R. Savioz, C. Martin, S. Craige, and T.A. Walele: A Randomized, Parallel Group Study to Evaluate the Safety Profile of an Electronic Vapour Product Over 12 Weeks; Regul. Toxicol. Pharmacol. 81 (2016) S1–S14. DOI: 10.1016/j.yrtph.2016.10.003
  226. Hecht, S.S., S.G. Carmella, D. Kotandeniya, M.E. Pillsbury, M. Chen, B.W. Ransom, R.I. Vogel, E. Thompson, S.E. Murphy, and D.K. Hatsukami: Evaluation of Toxicant and Carcinogen Metabolites in the Urine of E-Cigarette Users Versus Cigarette Smokers; Nicotine Tob. Res. 17 (2015) 704–709. DOI: 10.1093/ntr/ntu218
  227. Piper, M.E., T.B. Baker, N.L. Benowitz, K.H. Kobinsky, and D.E. Jorenby: Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers; Nicotine Tob. Res. 21 (2019) 1279–1284. DOI: 10.1093/ntr/nty231
  228. Chang, C.M., Y.-C. Cheng, T.M. Cho, E.V. Mishina, A.Y. Del Valle-Pinero, D.M. van Bemmel, and D.K. Hatsukami: Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop; Nicotine Tob. Res. 21 (2019) 3–13. DOI: 10.1093/ntr/ntx273
  229. Cibella, F., D. Campagna, P. Caponnetto, M.D. Amaradio, M. Caruso, C. Russo, D.W. Cockcroft, and R. Polosa: Lung Function and Respiratory Symptoms in a Randomized Smoking Cessation Trial of Electronic Cigarettes; Clin. Sci. 130 (2016) 1929–1937. DOI: 10.1042/CS20160268
  230. Polosa, R., J.B. Morjaria, P. Caponnetto, M. Caruso, D. Campagna, M.D. Amaradio, G. Ciampi, C. Russo, and A. Fisichella: Persisting Long Term Benefits of Smoking Abstinence and Reduction in Asthmatic Smokers Who Have Switched to Electronic Cigarettes; Discov. Med. 21 (2016) 99–108.
  231. Wieslander, G., D. Norbäck, and T. Lindgren: Experimental Exposure to Propylene Glycol Mist in Aviation Emergency Training: Acute Ocular and Respiratory Effects; Occup. Environ. Med. 58 (2001) 649–655. DOI: 10.1136/oem.58.10.649
  232. D’Ruiz, C.D., G. O’Connell, D.W. Graff, and X.S. Yan: Measurement of Cardiovascular and Pulmonary Function Endpoints and Other Physiological Effects Following Partial or Complete Substitution of Cigarettes with Electronic Cigarettes in Adult Smokers; Regul. Toxicol. Pharmacol. 87 (2017) 36–53. DOI: 10.1016/j.yrtph.2017.05.002
  233. Yuan, J.-M., S.G. Carmella, R. Wang, Y.T. Tan, J. Adams-Haduch, Y.T. Gao, and S.S. Hecht: Relationship of the Oxidative Damage Biomarker 8-epi-Prostaglandin F2α to Risk of Lung Cancer Development in the Shanghai Cohort Study; Carcinogenesis 39 (2018) 948–954. DOI: 10.1093/carcin/bgy060
  234. Oliveri, D., Q. Liang, and M. Sarkar: Real-World Evidence of Differences in Biomarkers of Exposure to Select Harmful and Potentially Harmful Constituents and Biomarkers of Potential Harm Between Adult E-Vapor Users and Adult Cigarette Smokers; Nicotine Tob. Res. 22 (2020) 1114–1122. DOI: 10.1093/ntr/ntz185
  235. Song, M.-A., J.L. Freidenheim, T.M. Brasky, E.A. Mathe, J.P. McElroy, Q.A. Nickerson, S.A. Reisinger, D.J. Smiraglia, D.Y. Weng, K.L. Ying, M.D. Wewers, and P.G. Shields: Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users; Cancer Epidemiol. Biomarkers Prev. 29 (2020) 443–451. DOI: 10.1158/1055-9965.EPI-19-1245
  236. Valavanidis, A., T. Vlachogianni, and C. Fiotakis: 8-Hydroxy-2'-deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis; J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 27 (2009) 120–139. DOI: 10.1080/10590500902885684
  237. George, J., M. Hussain, T. Vadiveloo, S. Ireland, P. Hopkinson, A.D. Struthers, P.T. Donnan, F. Khan, and C.C. Lang: Cardiovascular Effects of Switching from Tobacco Cigarettes to Electronic Cigarettes; J. Am. Coll. Cardiol. 74 (2019) 3112–3120. DOI: 10.1016/j.jacc.2019.09.067
  238. de Faria, A.P., R. Modolo, and H. Moreno: Plasma 8-Isoprostane as a Biomarker and Applications to Cardiovascular Disease; in: Biomarkers in Cardiovascular Disease, edited by V. Patel and V. Preedy, Springer, Dordrecht, The Netherlands, 2016. DOI: 10.1007/978-94-007-7741-5_31-1
  239. Wang, N., K.C. Vendrov, B.P. Simmons, R.N. Schuck, G.A. Stouffer, and C.R. Lee: Urinary 11-Dehydrothromboxane B2 Levels are Associated with Vascular Inflammation and Prognosis in Atherosclerotic Cardiovascular Disease; Prostaglandins Other Lipid Mediat. 134 (2018) 24–31. DOI: 10.1016/j.prostaglandins.2017.11.003
  240. Kuntic, M., M. Oelze, S. Steven, S. Kröller-Schön, P. Stamm, S. Kalinovic, K. Frenis, K. Vujacic-Mirski, M.T. Bayo Jimenez, M. Kvandova, K. Filippou, A. Al Zuabi, V. Brückl, O. Hahad, S. Daub, F. Varveri, T. Gori, R. Huesmann, T. Hoffmann, F.P. Schmidt, J.F. Keaney, A. Daiber, and T. Münzel: Short-Term E-Cigarette Vapour Exposure Causes Vascular Oxidative Stress and Dysfunction: Evidence for a Close Connection to Brain Damage and a Key Role of the Phagocytic NADPH Oxidase (NOX-2); Eur. Heart J. 41 (2020) 2472–2483. DOI: 10.1093/eurheartj/ehz772
  241. Kerr, D.M.I., K.J.M. Brooksbank, R.G. Taylor, K. Pinel, F.J. Rios, R.M. Touyz, and C. Delles; Acute Effects of Electronic and Tobacco Cigarettes on Vascular and Respiratory Function in Healthy Volunteers: A Cross-Over Study; J. Hypertens. 37 (2019) 154–166. DOI: 10.1097/HJH.0000000000001890
  242. Moheimani, R.S., M. Bhetraratana, K.M. Peters, B.K. Yang, F. Yin, J. Gornbein, J.A. Araujo, and H.R. Middlekauff: Sympathomimetic Effects of Acute E-Cigarette Use: Role of Nicotine and Non-Nicotine Constituents; J. Am. Heart Assoc. 6 (2017) e006579. DOI: 10.1161/JAHA.117.006579
  243. Gathright, E.C., W.-C. Wu, and L.A.J. Scott-Sheldon: Electronic Cigarette Use Among Heart Failure Patients: Findings from the Population Assessment of Tobacco and Health Study (Wave 1: 2013–2014); Heart Lung 9 (2020) 229–232. DOI: 10.1016/j.hrtlng.2019.11.006
  244. Flacco, M.E., M. Ferrante, M. Fiore, C. Marzuillo, C. La Vecchia, M.R. Gualano, G. Liguori, G. Fragassi, T. Carradori, F. Bravi, R. Siliquini, W. Ricciardi, P. Villari, and L. Manzoli: Cohort Study of Electronic Cigarette Use: Safety and Effectiveness After 4 Years of Follow-up; Eur. Rev. Med. Pharmacol. Sci. 23 (2019) 402–412. DOI: 10.26355/eurrev_201901_16789
  245. O’Connell, G., D.W. Graff, and C.D. D’Ruiz: Reductions in Biomarkers of Exposure (BoE) to Harmful or Potentially Harmful Constituents (HPHCs) Following Partial or Complete Substitution of Cigarettes with Electronic Cigarettes in Adult Smokers; Toxicol. Mech. Methods 26 (2016) 443–454. DOI: 10.1080/15376516.2016.1196282
  246. Claire, R., C. Chamberlain, M.-A. Davey, S.E. Cooper, I. Berlin, J. Leonardi-Bee, and T. Coleman: Pharmacological Interventions for Promoting Smoking Cessation During Pregnancy; Cochrane Database Syst. Rev. 3 (2020) CD010078. DOI: 10.1002/14651858.CD010078.pub3
  247. The American College of Obstetricians and Gynecologists (ACOG): Committee Opinion No. 807: Smoking Cessation During Pregnancy; 2020. Available at: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/05/tobacco-and-nicotine-cessation-during-pregnancy (accessed September 7, 2020)
  248. National Institute for Health and Care Excellence (NICE): Smoking: Harm Reduction; Public Health Guideline [PH 45] 2013. Available at: https://www.nice.org.uk/guidance/PH45 (accessed April 29, 2020)
  249. Berlin, I., G. Grangé, N. Jacob, and M.-L. Tanguy: Nicotine Patches in Pregnant Smokers: Randomised, Placebo Controlled, Multicentre Trial of Efficacy; BMJ 348 (2014) g1622. DOI: 10.1136/bmj.g1622
  250. Bowker, K., S. Lewis, T. Coleman, and S. Cooper: Changes in the Rate of Nicotine Metabolism Across Pregnancy: A Longitudinal Study; Addiction 110 (2015) 1827–1832. DOI: 10.1111/add.13029
  251. Singh, B., M. Hrywna, O.A. Wackowski, C.D. Delnevo, M. Jane Lewis, and M.B. Steinberg: Knowledge, Recommendation, and Beliefs of E-Cigarettes Among Physicians Involved in Tobacco Cessation: A Qualitative Study; Prev. Med. Rep. 8 (2017) 25–29. DOI: 10.1016/j.pmedr.2017.07.012
  252. Bowker, K., S. Orton, S. Cooper, F. Naughton, R. Whitemore, S. Lewis, L. Bauld, L. Sinclair, T. Coleman, A. Dickinson, and M. Ussher: Views on and Experiences of Electronic Cigarettes: A Qualitative Study of Women Who Are Pregnant or Have Recently Given Birth; BMC Pregnancy Childbirth 18 (2018) 233. DOI: 10.1186/s12884-018-1856-4
  253. McCubbin, A., A. Fallin-Bennet, J. Barnett, and K. Ashford: Perceptions and Use of Electronic Cigarettes in Pregnancy; Health Educ. Res. 32 (2017) 22–32. DOI: 10.1093/her/cyw059
  254. Shahab, L., F. Dobbie, R. Hiscock, A. McNeill, and L. Bauld: Prevalence and Impact of Long-Term Use of Nicotine Replacement Therapy in UK Stop-Smoking Services: Finding from the ELONS Study; Nicotine Tob. Res. 20 (2017) 81–88. DOI: 10.1093/ntr/ntw258
  255. Whittington J.R., P.M. Simmons, A.M. Phillips, S.K. Gammill, R. Cen, E.F. Magann, and V.M. Cardenas: The Use of Electronic Cigarettes in Pregnancy: A Review of the Literature; Obstet. Gynecol. Surv. 73 (2018) 544–549. DOI: 10.1097/OGX.0000000000000595
  256. Prochaska, J.J., S. Das, and K.C. Young-Wolff: Smoking, Mental Illness, and Public Health; Annu. Rev. Public Health 38 (2017) 165–185. DOI: 10.1146/annurev-publhealth-031816-044618
  257. Weinberger, A.H., J. Zhu, J.L. Barrington-Trimis, K. Wyka, and R.D. Goodwin: Cigarette Use, E-Cigarette Use, and Dual Product Use is Higher Among Adults with Serious Psychological Distress in the United States: 2014–2017; Nicotine Tob. Res. 22 (2020) 1875–1882. DOI: 10.1093/ntr/ntaa061
  258. Cummins, S.E., S.H. Zhu, G.J. Tedeschi, A.C. Gamst, and M.G. Myers: Use of E-Cigarettes by Individuals with Mental Health Conditions; Tob. Control 23 (2014) iii48–iii53. DOI: 10.1136/tobaccocontrol-2013-051511
  259. Peckham, E., M. Mishu, C. Fairhurst, D. Robson, T. Bradshaw, C. Arundel, D. Bailey, P. Heron, S. Ker, and S. Gilbody: E-Cigarette Use and Associated Factors Among Smokers with Severe Mental Illness; Addict. Behav. 108 (2020) 106456. DOI: 10.1016/j.addbeh.2020.106456
  260. Sheals, K., I. Tombor, A. McNeill, and L. Shahab: A Mixed-Method Systematic Review and Meta-Analysis of Mental Health Professionals’ Attitudes Toward Smoking and Smoking Cessation Among People with Mental Illnesses; Addiction 111 (2016) 1536–1553. DOI: 10.1111/add.13387
  261. Siru, R., G.K. Hulse, and R.J. Tait: Assessing Motivation to Quit Smoking in People with Mental Illness: A Review; Addiction 104 (2009) 719–733. DOI: 10.1111/j.1360-0443.2009.02545.x
  262. Action on Smoking and Health (ASH): Fact Sheet No. 12: Smoking and Mental Health; 2019. Available at: https://ash.org.uk/wp-content/uploads/2019/08/ASH-Factsheet_Mental-Health_v3-2019-27-August-1.pdf (accessed April 29, 2020)
  263. Reibel, J.: Tobacco and Oral Diseases. Update on the Evidence with Recommendations; Med. Princ. Pract. 12 (2003) 22–32. DOI: 10.1159/000069845
  264. BinShabaib, M., S.S. ALHarthi, Z. Akram, J. Khan, I. Rahman, G.E. Romanos, and F. Javed: Clinical Periodontal Status and Gingival Crevicular Fluid Cytokine Profile Among Cigarette-Smokers, Electronic-Cigarette Users and Never-Smokers; Arch. Oral Biol. 102 (2019) 212–217. DOI: 10.1016/j.archoralbio.2019.05.001
  265. Ye, D., S. Gajendra, G. Lawyer, N. Jadeja, D. Pishey, S. Pathagunti, J. Lyons, P. Veazie, G. Watson, S. McIntosh, and I. Rahman: Inflammatory Biomarkers and Growth Factors in Saliva and Gingival Crevicular Fluid of E-cigarette Users, Cigarette Smokers, and Dual Smokers: A Pilot Study; J. Periodontol. 91 (2020) 1274–1283. DOI: 10.1002/JPER.19-0457
  266. Yang, I., S. Sandeep, and J. Rodriguez: The Oral Health Impact of Electronic Cigarette Use: A Systematic Review; Crit. Rev. Toxicol. 50 (2020) 97–127. DOI: 10.1080/10408444.2020.1713726
  267. Dalrymple, A., T.C. Badrock, A. Terry, M. Barber, P.J. Hall, D. Thorne, M.D. Gaça, S. Coburn, and C. Proctor: Assessment of Enamel Discoloration In Vitro Following Exposure to Cigarette Smoke and Emissions from Novel Vapor and Tobacco Heating Products; Am. J. Dent. 31 (2018) 227–233.
  268. Dalrymple, A., T.C. Badrock, A. Terry, E.J. Bean, M. Barber, P.J. Hall, S. Coburn, J. McAughey, and J. Murphy: Development of a Novel Method to Measure Material Surface Staining by Cigarette, E-Cigarette or Tobacco Heating Product Aerosols; Heliyon 6 (2020) e05012. DOI: 10.1016/j.heliyon.2020.e05012
  269. Persoskie, A., E.K. O’Brien, and K. Poonai: Perceived Relative Harm of Using E-Cigarettes Predicts Future Product Switching Among US Adult Cigarette and E-Cigarette Dual Users; Addiction 114 (2019) 2197–2205. DOI: 10.1111/add.14730
  270. Gravely, S., P. Driezen, C.N. Kyriakos, M.E. Thompson, J. Balmford, T. Demjén, E. Fernández, U. Mons, Y. Tountas, K. Janik-Koncewicz, W. Zatoński, A.C. Trofor, C.I. Vardavas, G.T. Fong, and the EUREST-PLUS Consortium: European Adult Smokers’ Perceptions of the Harmfulness of E-Cigarettes Relative to Combustible Cigarettes: Cohort Findings from the 2016 and 2018 EUREST-PLUS ITC Europe Surveys; Eur. J. Public Health. 30 (2020) iii38–iii45. DOI: 10.1093/eurpub/ckz215
  271. Huang, J., B. Feng, S.R. Weaver, T.F. Pechacek, P. Slovic, and M.P. Eriksen: Changing Perceptions of Harm of E-Cigarette vs Cigarette Use Among Adults in 2 US National Surveys from 2012 to 2017; JAMA Netw. Open 2 (2019) e191047. DOI: 10.1001/jamanetworkopen.2019.1047
  272. Malt, L., T. Verron, X. Cahours, M. Guo, S. Weaver, T. Walele, and G. O’Connell: Perception of the Relative Harm of Electronic Cigarettes Compared to Cigarettes Amongst US Adults from 2013 to 2016: Analysis of the Population Assessment of Tobacco and Health (PATH) Study Data; Harm Reduct. J. 17 (2020) 65. DOI: 10.1186/s12954-020-00410-2
  273. Romijnders, K.A.G.J., L. van Osch, H. de Vries, and R. Talhout: Perceptions and Reasons Regarding E-Cigarette Use Among Users and Non-Users: A Narrative Literature Review; Int. J. Environ. Res. Public Health 15 (2018) 1190. DOI: 10.3390/ijerph15061190
  274. Sussan, T.E., F.G. Shahzad, E. Tabassum, J.E. Cohen, R.A. Wise, M.J. Blaha, J.T. Holbrook, and S. Biswal: Electronic Cigarette Use Behaviors and Motivations Among Smokers and Non-Smokers; BMC Public Health 17 (2017) 686. DOI: 10.1186/s12889-017-4671-3
  275. European Commission: Special Eurobarometer 429. Attitudes of Europeans Towards Tobacco and Electronic Cigarettes; 2015. Available at: https://ec.europa.eu/commfrontoffice/publicopinion/archives/ebs/ebs_429_en.pdf (accessed January 6 2021).
  276. Action on Smoking and Health (ASH): Use of E-Cigarettes (Vaporisers) Among Adults in Great Britain; 2019. Available at: https://ash.org.uk/wp-content/uploads/2019/09/ASH-Factsheet_Adult-ECigs-2019-Final-3.pdf (accessed January 6 2021).
  277. Mayo Clinic: Quit-Smoking Products: Boost Your Chance of Success; 2020. Available at: https://www.mayoclinic.org/healthy-lifestyle/quit-smoking/in-depth/quit-smoking-products/art-20045599 (accessed September 7, 2020)
  278. Bullen, C., C. Howe, M. Laugesen, H. McRobbie, V. Parag, J. Williman, and N. Walker: Electronic Cigarettes for Smoking Cessation: A Randomised Controlled Trial; Lancet 382 (2013) 1629–1637. DOI: 10.1016/S0140-6736(13)61842-5
  279. Farsalinos, K.E. and R. Niaura: E-Cigarettes and Smoking Cessation in the United States According to Frequency of E-Cigarette Use and Quitting Duration: Analysis of the 2016 and 2017 National Health Interview Surveys; Nicotine Tob. Res. 22 (2020) 655–662. DOI: 10.1093/ntr/ntz025
  280. Carter, L.P., M.L. Stitzer, J.E. Henningfield, R.J. O’Connor, K.M. Cummings, and D.K. Hatsukami: Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3241–3262. DOI: 10.1158/1055-9965.EPI-09-0948
  281. Caponnetto, P., D. Campagna, G. Papale, C. Russo, and R. Polosa: The Emerging Phenomenon of Electronic Cigarettes; Expert Rev. Respir. Med. 6 (2012) 63–74. DOI: 10.1586/ers.11.92
  282. Hajek, P.: Electronic Cigarettes Have a Potential for Huge Public Health Benefit; BMC Med. 12 (2014) 225. DOI: 10.1186/s12916-014-0225-z
  283. Hatsukami, D.K.: Ending Tobacco-Caused Mortality and Morbidity: The Case for Performance Standards for Tobacco Products; Tob. Control 22 (2013) i36–i37. DOI: 10.1136/tobaccocontrol-2012-050785
  284. Institute of Medicine (IOM): Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research; National Academies Press, Washington, DC, USA, 2011.
  285. Walton, K.M., D.B. Abrams, W.C. Bailey, D. Clark, G.N. Connolly, M.V. Djordjevic, T.E. Eissenberg, M.C. Fiore, M.L. Goniewicz, L. Haverkos, S.S. Hecht, J.E. Henningfield, J.R. Hughes, C.A. Oncken, L. Postow, J.E. Rose, K.L. Wanke, L. Yang, and D.K. Hatsukami: NIH Electronic Cigarette Workshop: Developing a Research Agenda; Nicotine Tob. Res. 17 (2015) 259–69. DOI: 10.1093/ntr/ntu214
  286. U.S. Department of Health and Human Services (DHHS), Center for Drug Evaluation and Research: Assessment of Abuse Potential of Drugs: Guidance for Industry; 2017. Available at: https://www.fda.gov/media/116739/download (accessed September 7, 2020)
  287. Maloney, S.F., A. Breland, E.K. Soule, M. Hiler, C. Ramôa, T. Lipato, and T. Eissenberg: Abuse Liability Assessment of an Electronic Cigarette in Combustible Cigarette Smokers; Exp. Clin. Psychopharmacol. 27 (2019) 443–454. DOI: 10.1037/pha0000261
  288. Liu, G., E. Wasserman, L. Kong, and J. Foulds: A Comparison of Nicotine Dependence Among Exclusive E-Cigarette and Cigarette Users in the PATH Study; Prev. Med. 104 (2017) 86–91. DOI: 10.1016/j.ypmed.2017.04.001
  289. Strong, D.R., J. Pearson, S. Ehlke, T. Kirchner, D. Abrams, K. Taylor, W.M. Compton, K.P. Conway, E. Lambert, V.R. Green, L.C. Hull, S.E. Evans, K.M. Cummings, M. Goniewicz, A. Hyland, and R. Niaura: Indicators of Dependence for Different Types of Tobacco Product Users: Descriptive Findings from Wave 1 (2013–2014) of the Population Assessment of Tobacco and Health (PATH) Study; Drug Alcohol Depend. 178 (2017) 257–266. DOI: 10.1016/j.drugalcdep.2017.05.010
  290. Rostron, B.L., M.J. Schroeder, and B.K. Ambrose: Dependence Symptoms and Cessation Intentions Among US Adult Daily Cigarette, Cigar, and E-Cigarette Users, 2012–2013; BMC Public Health 16 (2016) 814. DOI: 10.1186/s12889-016-3510-2
  291. McNeill, A., P. Driezen, S.C. Hitchman, K.M. Cummings, G.T. Fong, R. Borland: Indicators of Cigarette Smoking Dependence and Relapse in Former Smokers Who Vape Compared with Those Who Do Not: Findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey; Addiction 114 (2019) 49–60. DOI: 10.1111/add.14722
  292. Kapan, A., S. Stefanac, I. Sandner, S. Haider, I. Grabovac, and T.E. Dorner: Use of Electronic Cigarettes in European Populations: A Narrative Review; Int. J. Environ. Res. Public Health 17 (2020) 1971. DOI: 10.3390/ijerph17061971
  293. Levy, D.T., Z. Yuan, and Y. Li: The Prevalence and Characteristics of E-Cigarette Users in the U.S.; Int. J. Environ. Res. Public Health 14 (2017) 1200. DOI: 10.3390/ijerph14101200
  294. Office for National Statistics: E-Cigarette Use in Great Britain; 2020. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/drugusealcoholandsmoking/datasets/ecigaretteuseingreatbritain (accessed January 6, 2021)
  295. Piñeiro, B., J.B. Correa, V.N. Simmons, P.T. Harrell, N.S. Menzie, M. Unrod, L.R. Meltzer, and T.H. Brandon: Gender Differences in Use and Expectancies of E-Cigarettes: Online Survey Results; Addict. Behav. 52 (2016) 91–97. DOI: 10.1016/j.addbeh.2015.09.006
  296. Andler, R., R. Guignard, J.L. Wilquin, F. Beck, J.B. Richard, and V. Nguyen-Thanh: Electronic Cigarette Use in France in 2014; Int. J. Public Health 61 (2016) 159–65. DOI: 10.1007/s00038-015-0773-9
  297. Farsalinos, K.E., K. Poulas, V. Voudris, and J. Le Houezec: Electronic Cigarette Use in the European Union: Analysis of a Representative Sample of 27 460 Europeans from 28 Countries; Addiction 111 (2016) 2032–2040. DOI: 10.1111/add.13506
  298. Filippidis, F.T., V. Gerovasili, and A.A. Laverty: Commentary on Farsalinos et al. (2016): Electronic Cigarette Use in the European Union: Analysis of a Representative Sample of 27 460 Europeans from 28 countries; Addiction 112 (2017) 544–545. DOI: 10.1111/add.13553
  299. Adams, J.M.: Surgeon General's Advisory on E-Cigarette Use Among Youth; 2018. Available at: https://e-cigarettes.surgeongeneral.gov/documents/surgeon-generals-advisory-on-e-cigarette-use-among-youth-2018.pdf (accessed September 7 2020).
  300. Bauld, L., A.M. MacKintosh, B. Eastwood, A. Ford, G. Moore, M. Dockrell, D. Arnott, H. Cheeseman, and A. McNeill: Young People's Use of E-Cigarettes Across the United Kingdom: Findings from Five Surveys 2015–2017; Int. J. Environ. Res. Public Health 14 (2017) 973. DOI: 10.3390/ijerph14090973
  301. Anic, G.M., M.D. Sawdey, A. Jamal, and K.F. Trivers: Frequency of Use Among Middle and High School Student Tobacco Product Users – United States, 2015–2017; MMWR Morb. Mortal. Wkly. Rep. 67 (2018) 1353–1357. DOI: 10.15585/mmwr.mm6749a1
  302. National Institutes of Health (NIH), National Cancer Institute: Cancer Trends Progress Report: Tobacco Use Initiation; 2020. Available at: https://progressreport.cancer.gov/prevention/smoking_initiation (accessed January 6, 2021)
  303. World Health Organization (WHO): European Tobacco Use: Trends Report 2019; WHO, Regional Office for Europe, 2019. Available at: https://www.euro.who.int/__data/assets/pdf_file/0009/402777/Tobacco-Trends-Report-ENG-WEB.pdf (accessed January 6, 2021)
  304. Laverty, A.A., E.P. Vamos, and F. Filippidis: Uptake of E-Cigarettes Among a Nationally Representative Cohort of UK Children; Tob. Prev. Cessat. 4 (2018) 16. DOI: 10.18332/tpc/89727
  305. Zhang, X. and J. Pu: E-Cigarette Use Among US Adolescents: Secondhand Smoke at Home Matters; Int. J. Public Health 61 (2016) 209–213. DOI: 10.1007/s00038-015-0784-6
  306. Vu, T.-H.T., A. Goom, J.L. Hart, H. Tran, R.L. Landry, J.Z. Ma, K.L. Walker, A.L. Giachello, A. Kesh, T.J. Payne, and R.M. Robertson: Socioeconomic and Demographic Status and Perceived Health Risks of E-Cigarette Product Contents Among Youth: Results from a National Survey; Health Promot. Pract. 21 (2020) 148S–156S. DOI: 10.1177/1524839919882700
  307. Amin, S., A.G. Dunn, and L. Laranjo: Social Influence in the Uptake and Use of Electronic Cigarettes: A Systematic Review; Am. J. Prev. Med. 58 (2020) 129–141. DOI: 10.1016/j.amepre.2019.08.023
  308. Kozlowski, L. and E.W. Warner: Adolescents and E-Cigarettes: Objects of Concern May Appear Larger Than They Are; Drug Alcohol Depend. 174 (2017) 209–214. DOI: 10.1016/j.drugalcdep.2017.01.001
  309. Australian Government, Department of Health: Personal Importation Scheme; 2015. Available at: https://www.tga.gov.au/personal-importation-scheme (accessed January 4 2021).
  310. O’Leary, R., M. MacDonald, T. Stockwell, and D. Reist: Clearing the Air: A Systematic Review on the Harms and Benefits of E-Cigarettes and Vapour Devices; Canadian Institute for Substance Use Research, Victoria, BC, 2017.
  311. Royal College of Physicians: Nicotine Without Smoke: Tobacco Harm Reduction; Royal College of Physicians, London, UK, 2016. Available at: https://bit.ly/3677LeX
  312. Mendelsohn, C.P. and W. Hall: Does the Gateway Theory Justify a Ban on Nicotine Vaping in Australia?; Int. J. Drug Policy 78 (2020) 102712. DOI: 10.1016/j.drugpo.2020.102712
  313. Kasza, K.A., K.C. Edwards, Z. Tang, C.A. Stanton, E. Sharma, M.J. Halenar, K.A. Taylor, E. Donaldson, L.C. Hull, H. Day, M. Bansal-Travers, J. Limpert, I. Zandberg, L.D. Gardner, H.T. Hammad, N. Borek, H.L. Kimmel, W.M. Compton, and A. Hyland: Correlates of Tobacco Product Initiation Among Youth and Adults in the USA: Findings from the PATH Study Waves 1–3 (2013–2016); Tob. Control 29 (2020) s191–s202. DOI: 10.1136/tobaccocontrol-2020-055671
  314. Khouja, J.N., R.E. Wootton, A.E. Taylor, G. Davey Smith, and M.R. Munafò: Association of Genetic Liability to Smoking Initiation with E-Cigarette Use in Young Adults: A Cohort Study; PLoS Med. 18 (2021) e1003555. DOI: 10.1371/journal.pmed.1003555
  315. Hall, W. and G. Chan: The “Gateway” Effect of E-Cigarettes May be Explained by a Genetic Liability to Risk-Taking; PLoS Med. 18 (2021) e1003554. DOI: 10.1371/journal.pmed.1003554
  316. Auf, R., M.J. Trepka, M. Selim, Z. Ben Taleb, M. De La Rosa, E. Bastida and M.Á. Cano: E-Cigarette Use is Associated with Other Tobacco Use Among US Adolescents; Int. J. Public Health 64 (2019) 125–134. DOI: 10.1007/s00038-018-1166-7
  317. Evans-Polce, R.J., P. Veliz, C.J. Boyd, and S.B. McCabe: Initiation Patterns and Trends of E-Cigarette and Cigarette Use Among U.S. Adolescents; J. Adolesc. Health 66 (2020) 27–33. DOI: https://doi.org/10.1016/j.jadohealth.2019.07.002
  318. Walker, N., V. Parag, S.F. Wong, B. Youdan, B. Broughton, C. Bullen, and R. Beaglehole: Use of E-Cigarettes and Smoked Tobacco in Youth Aged 14–15 Years in New Zealand: Findings from Repeated Cross-Sectional Studies (2014–19); Lancet Public Health 5 (2020) e204–e212. DOI: 10.1016/S2468-2667(19)30241-5
  319. Government of Canada: Exploratory Research on Youth Vaping: Final Report / Prepared for Health Canada; Supplier Name: Quorus Consulting Group Inc., Ottawa, Canada, 2020. Available at: http://publications.gc.ca/site/fra/9.886111/publication.html (accessed January, 6 2021)
  320. Cunningham, A., S. Slayford, C. Vas, J. Gee, S. Costigan, and K. Prasad; Development, Validation and Application of a Device to Measure E-Cigarette Users’ Puffing Topography; Sci. Rep. 6 (2016) 35071. DOI: 10.1038/srep35071
  321. Slayford, S.J. and B.E. Frost: A Device to Measure a Smoker's Puffing Topography and Real-Time Puff-by-Puff “Tar” Delivery; Beitr. Tabakforsch. Int. 26 (2014) 74–84. DOI: 10.2478/cttr-2014-0011
  322. Jones, J., S. Slayford, A. Gray, K. Brick, K. Prasad, and C.A. Proctor: A Cross-Category Puffing Topography, Mouth Level Exposure and Consumption Study Among Italian Users of Tobacco and Nicotine Products; Sci. Rep. 10 (2020) 12. DOI: 10.1038/s41598-019-55410-5
  323. Hammond, D., G.T. Fong, K.M. Cummings, and A. Hyland: Smoking Topography, Brand Switching, and Nicotine Delivery: Results from an In Vivo Study; Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1370–1375. DOI: 10.1158/1055-9965.EPI-04-0498
  324. Spindle, T.R., A.B. Breland, N.V. Karaoghlanian, A.L. Shihadeh, and T. Eissenberg: Preliminary Results of an Examination of Electronic Cigarette User Puff Topography: The Effect of a Mouthpiece-Based Topography Measurement Device on Plasma Nicotine and Subjective Effects; Nicotine Tob. Res. 17 (2015) 142–149. DOI: 10.1093/ntr/ntu186
  325. European Medicines Agency (EMA): Biosimilars in the EU: Information Guide for Healthcare Professionals; 2019. Available at: https://www.ema.europa.eu/en/documents/leaflet/biosimilars-eu-information-guide-healthcare-professionals_en.pdf (accessed January 6, 2021)
  326. Goodchild, M., A.-M. Perucic, and N. Nargis: Modelling the Impact of Raising Tobacco Taxes on Public Health and Finance; Bull. World Health Organ. 94 (2016) 250–257. DOI: 10.2471/BLT.15.164707
  327. Levy, D.T., J.L. Pearson, A.C. Villanti, K. Blackman, D.M. Vallone, R.S. Niaura, and D.B. Abrams: Modeling the Future Effects of a Menthol Ban on Smoking Prevalence and Smoking-Attributable Deaths in the United States; Am. J. Public Health 101 (2011) 1236–1240. DOI: 10.2105/AJPH.2011.300179.
  328. Wallace, R., A. Geller, and V.A. Ogawa: Assessing the Use of Agent-Based Models for Tobacco Regulation. Consensus Study Report; National Academies Press, Washington, DC, USA, 2015. DOI: 10.17226/19018
  329. Vugrin, E.D., B.L. Rostron, S.J. Verzi, N.S. Brodsky, T.J. Brown, C.J. Choiniere, B.N. Coleman, A. Paredes, and B.J. Apelberg: Modeling the Potential Effects of New Tobacco Products and Policies: A Dynamic Population Model for Multiple Product Use and Harm; PLoS One 10 (2015) e0121008. DOI: 10.1371/journal.pone.0121008
  330. Bachand, A.M. and S.I. Sulsky: A Dynamic Population Model for Estimating All-Cause Mortality Due to Lifetime Exposure History; Regul. Toxicol. Pharmacol. 67 (2013) 246–251. DOI: 10.1016/j.yrtph.2013.08.003
  331. Levy, D.T., N. Nikolayev, E.A. Mumford, and C. Compton: The Healthy People 2010 Smoking Prevalence and Tobacco Control Objectives: Results from the SimSmoke Tobacco Control Policy Simulation Model (United States); Cancer Causes Control 16 (2005) 359–371. DOI: 10.1007/s10552-004-7841-4
  332. Lee, P.N., D. Abrams, A. Bachand, G. Baker, R. Black, O. Camacho, G. Curtin, S. Djurdjevic, A. Hill, D. Mendez, R.S. Muhammad-Kah, J.L. Murillo, R. Niaura, Y.B. Pithawalla, B. Poland, S. Sulsky, L. Wei, and R. Weitkunat: Estimating the Population Health Impact of Recently Introduced Modified Risk Tobacco Products: A Comparison of Different Approaches; Nicotine Tob. Res. 23 (2021) 426–437. DOI: 10.1093/ntr/ntaa102
  333. Warner, K.E. and D. Mendez: E-Cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation; Nicotine Tob. Res. 21 (2019) 41–47. DOI: 10.1093/ntr/nty062
  334. Levy, D.T., R. Borland, E.N. Lindblom, M.L. Goniewicz, R. Meza, T.R. Holford, Z. Yuan, Y. Luo, R.J. O’Connor, R. Niaura, and D.B. Abrams: Potential Deaths Averted in USA by Replacing Cigarettes with E-Cigarettes; Tob. Control 27 (2018) 18–25. DOI: 10.1136/tobaccocontrol-2017-053759
  335. Bachand, A.M., S.I. Sulsky, and G.M. Curtin: Assessing the Likelihood and Magnitude of a Population Health Benefit Following the Market Introduction of a Modified-Risk Tobacco Product: Enhancements to the Dynamic Population Modeler, DPM(+1); Risk Anal. 38 (2018) 151–162. DOI: 10.1111/risa.12819
  336. Cherng, S.T., J. Tam, P.J. Christine, and R. Meza: Modeling the Effects of E-Cigarettes on Smoking Behavior: Implications for Future Adult Smoking Prevalence; Epidemiology 27 (2016) 819–826. DOI: 10.1097/EDE.0000000000000497
  337. Soneji, S.S., H.-Y. Sung, B.A. Primack, J.P. Pierce, and J.D. Sargent: Quantifying Population-Level Health Benefits and Harms of E-Cigarette Use in the United States; PLoS One 23 (2018) e0193328. DOI: 10.1371/journal.pone.0193328
  338. Hill, A. and O.M. Camacho: A System Dynamics Modelling Approach to Assess the Impact of Launching a New Nicotine Product on Population Health Outcomes; Regul. Toxicol. Pharmacol. 86 (2017) 265–278. DOI: 10.1016/j.yrtph.2017.03.012
  339. U.S. Food and Drug Administration (FDA): Generally Recognized as Safe (GRAS); 2019. Available at: https://www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras (accessed January 25, 2021)
  340. Akiyama, Y. and N. Sherwood: Systematic Review of Biomarker Findings from Clinical Studies of Electronic Cigarettes and Heated Tobacco Products; Toxicol. Rep. 8 (2021) 282–294. DOI: 10.1016/j.toxrep.2021.01.014
  341. Office for National Statistics: Adult Smoking Habits in Great Britain; 2020. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/drugusealcoholandsmoking/datasets/adultsmokinghabitsingreatbritain (accessed January 6, 2021)
  342. Jaccard, G., T. Tafin Djoko, A. Korneliou, R. Stabbert, M. Belushkin, and M. Esposito: Mainstream Smoke Constituents and In Vitro Toxicity Comparative Analysis of 3R4F and 1R6F Reference Cigarettes; Toxicol. Rep. 6 (2019) 222–231. DOI: 10.1016/j.toxrep.2019.02.009
  343. O’Connell, G., T. Walele, C. Prue, G. Gillman, X. Cahours, O. Hibbert, and J.D. Pritchard: Chemical Composition of Myblu™ Pod-System E-Cigarette Aerosols: A Quantitative Comparison with Conventional Cigarette Smoke; presented at the 1st Scientific Summit on Tobacco Harm Reduction, Kallithea, Greece, June 2018. Available at: https://imperialbrandsscience.com/wp-content/uploads/2020/02/Chemical-Composition-of-blu-Pod-System-EVP-Aerosols-A-Quantitative-Comparison-with-Conventional-Cigarette-Smoke.pdf (accessed May 8, 2021)
  344. Farsalinos, K., K. Poulas, and V. Voudris: Changes in Puffing Topography and Nicotine Consumption Depending on the Power Setting of Electronic Cigarettes; Nicotine Tob. Res. 20 (2018) 993–997. DOI: 10.1093/ntr/ntx219
  345. Yan, X.S. and C. D’Ruiz: Effects of Using Electronic Cigarettes on Nicotine Delivery and Cardiovascular Function in Comparison with Regular Cigarettes; Regul. Toxicol. Pharmacol. 71 (2015) 24–34. DOI: 10.1016/j.yrtph.2014.11.004
  346. Hajek, P., D. Przulj, A. Phillips, R. Anderson, and H. McRobbie: Nicotine Delivery to Users from Cigarettes and from Different Types of E-Cigarettes; Psychopharmacology 234 (2017) 773–779. DOI: 10.1007/s00213-016-4512-6
  347. Vansickel, A.R., C.O. Cobb, M.F. Weaver, and T.E. Eissenberg: A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic “Cigarettes”: Nicotine Delivery Profile and Cardiovascular and Subjective Effects; Cancer Epidemiol. Biomarkers Prev. 19 (2010) 1945–1953. DOI: 10.1158/1055-9965.EPI-10-0288
  348. Voos, N., L. Kaiser, M.C. Mahoney, C.M. Bradizza, L.T. Kozlowski, N.L. Benowitz, R.J. O’Connor, and M.L. Goniewicz: Randomized Within-Subject Trial to Evaluate Smokers’ Initial Perceptions, Subjective Effects and Nicotine Delivery Across Six Vaporized Nicotine Products; Addiction 114 (2019) 1236–1248. DOI: 10.1111/add.14602
  349. Lunell, E. and M. Curvall: Nicotine Delivery and Subjective Effects of Swedish Portion Snus Compared with 4 mg Nicotine Polacrilex Chewing Gum; Nicotine Tob. Res. 13 (2011) 573–578. DOI: 10.1093/ntr/ntr044
  350. Dautzenberg, B., M. Nides, J.L. Kienzler, and A. Callens: Pharmacokinetics, Safety and Efficacy from Randomized Controlled Trials of 1 and 2 mg Nicotine Bitartrate Lozenges (Nicotinell®); BMC Clin. Pharmacol. 7 (2007) 11. DOI: 10.1186/1472-6904-7-11
  351. Choi, J.H., C.M. Dresler, M.R. Norton, and K.R. Strahs: Pharmacokinetics of a Nicotine Polacrilex Lozenge; Nicotine Tob. Res. 5 (2003) 635–644. DOI: 10.1080/1462220031000158690
  352. Kraiczi, H., A. Hansson, and R. Perfekt: Single-Dose Pharmacokinetics of Nicotine When Given with a Novel Mouth Spray for Nicotine Replacement Therapy; Nicotine Tob. Res. 13 (2011) 1176–1182. DOI: 10.1093/ntr/ntr139
  353. Molander, L. and E. Lunell: Pharmacokinetic Investigation of a Nicotine Sublingual Tablet; Eur. J. Clin. Pharmacol. 56 (2001) 813–819. DOI 10.1007/s002280000223
  354. Lunell, E., K. Fagerström, J. Hughes, and R. Pendril: Pharmacokinetic Comparison of a Novel Non-Tobacco-Based Nicotine Pouch (ZYN) with Conventional, Tobacco-Based Swedish Snus and American Moist Snuff; Nicotine Tob. Res. 22 (2020) 1757–1763. DOI: 10.1093/ntr/ntaa068
  355. Goldenson, N., I.M. Fearon, A.R. Buchhalter, and J.E. Heningfield: An Open-Label, Randomised, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers; Nicotine Tob. Res. (2021) ntab001. DOI: 10.1093/ntr/ntab001
  356. D’Ruiz, C.D., D.W. Graff, and E. Robinson: Reductions in Biomarkers of Exposure, Impacts on Smoking Urge and Assessment of Product Use and Tolerability in Adult Smokers Following Partial or Complete Substitution of Cigarettes with Electronic Cigarettes; BMC Public Health 16 (2016) 543. DOI: 10.1186/s12889-016-3236-1
  357. Campagna, D., F. Cibella, P. Caponnetto, M.D. Amaradio, M. Caruso, J.B. Morjaria, M. Malerba, and R. Polosa: Changes in Breathomics from a 1-Year Randomized Smoking Cessation Trial of Electronic Cigarettes; Eur. J. Clin. Invest. 46 (2016) 698–706. DOI: 10.1111/eci.12651
  358. Pulvers, K., A.S. Emami, N.L. Nollen, D.R. Romero, D.R. Strong, N.L. Benowitz, and J.S. Ahluwalia: Tobacco Consumption and Toxicant Exposure of Cigarette Smokers Using Electronic Cigarettes; Nicotine Tob. Res. 20 (2018) 206–214. DOI: 10.1093/ntr/ntw333
  359. Behar, R.Z., M. Hua, and P. Talbot: Puffing Topography and Nicotine Intake of Electronic Cigarette Users; PLoS One 10 (2015) e0117222. DOI: 10.1371/journal.pone.0117222
  360. Norton, K.J., K.M. June, and R.J. O’Connor: Initial Puffing Behaviors and Subjective Responses Differ Between an Electronic Nicotine Delivery System and Traditional Cigarettes; Tob. Induc. Dis. 12 (2014) 17. DOI: 10.1186/1617-9625-12-17
  361. Lee, Y.H., M. Gawron, and M.L. Goniewicz: Changes in Puffing Behavior Among Smokers Who Switched from Tobacco to Electronic Cigarettes; Addict. Behav. 48 (2015) 1–4. DOI: 10.1016/j.addbeh.2015.04.003
  362. Robinson, R.J., E.C. Hensel, P.N. Morabito, and K.A. Roundtree: Electronic Cigarette Topography in the Natural Environment; PLoS One 10 (2015) e0129296. DOI: 10.1371/journal.pone.0129296
  363. Robinson, R.J., E.C. Hensel, K.A. Roundtree, A.G. Difrancesco, J.M. Nonnemaker, and Y.O. Lee: Week Long Topography Study of Young Adults Using Electronic Cigarettes in Their Natural Environment; PloS One 11 (2016) e0164038. DOI: 10.1371/journal.pone.0164038
  364. Dawkins, L.E., C.F. Kimber, M. Doig, C. Feyerabend, and O. Corcoran: Self-Titration by Experienced E-Cigarette Users: Blood Nicotine Delivery and Subjective Effects; Psychopharmacology 233 (2016) 1–9. DOI: 10.1007/s00213-016-4338-2
  365. Lee, Y.O., J.M. Nonnemaker, B. Bradfield, E.C. Hensel, and R.J. Robinson: Examining Daily Electronic Cigarette Puff Topography Among Established and Nonestablished Cigarette Smokers in Their Natural Environment; Nicotine Tob. Res. 20 (2018) 1283–1288. DOI: 10.1093/ntr/ntx222
  366. Levy, D.T., R. Borland, A.C. Villanti, R. Niaura, Z. Yuan, Y. Zhang, R. Meza, T.R. Holford, G.T. Fong, K.M. Cummings, and D.B. Abrams: The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States; Nicotine Tob. Res. 19 (2017) 149–159. DOI: 10.1093/ntr/ntw158
  367. Levy, D.T., Z. Yuan, Y. Li, A.J. Alberg, and K.M. Cummings: A Modeling Approach to Gauging the Effects of Nicotine Vaping Product Use on Cessation from Cigarettes: What Do We Know, What Do We Need to Know?; Addiction 114 (2019) 86–96. DOI: 10.1111/add.14530
  368. Petrović-van der Deen, F.S., N. Wilson, A. Crothers, C.L. Cleghorn, C. Garner, and T. Blakely: Potential Country-Level Health and Cost Impacts of Legalizing Domestic Sale of Vaporized Nicotine Products; Epidemiology 30 (2019) 396–404. DOI: 10.1097/EDE.0000000000000975
  369. Kalkhoran, S. and S.A. Glantz: Modeling the Health Effects of Expanding E-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis; JAMA Intern. Med. 175 (2015) 1671–1680. DOI: 10.1001/jamainternmed.2015.4209
Language: English
Page range: 63 - 108
Submitted on: Feb 9, 2021
Accepted on: May 4, 2021
Published on: May 20, 2021
Published by: Institut für Tabakforschung GmbH
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Oscar M. Camacho, James K. Ebajemito, Steven Coburn, Krishna Prasad, Sandra Costigan, James J. Murphy, published by Institut für Tabakforschung GmbH
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.

Volume 30 (2021): Issue 2 (May 2021)